WO2018097388A1 - Composition for skin whitening, wrinkle alleviation, antioxidation, and ultraviolet light blocking, containing jujube seed extract as active ingredient - Google Patents

Composition for skin whitening, wrinkle alleviation, antioxidation, and ultraviolet light blocking, containing jujube seed extract as active ingredient Download PDF

Info

Publication number
WO2018097388A1
WO2018097388A1 PCT/KR2016/015026 KR2016015026W WO2018097388A1 WO 2018097388 A1 WO2018097388 A1 WO 2018097388A1 KR 2016015026 W KR2016015026 W KR 2016015026W WO 2018097388 A1 WO2018097388 A1 WO 2018097388A1
Authority
WO
WIPO (PCT)
Prior art keywords
seed extract
jujube seed
skin
ethanol
jujube
Prior art date
Application number
PCT/KR2016/015026
Other languages
French (fr)
Korean (ko)
Inventor
강연자
김진철
박종국
정용하
전동하
천정윤
박상미
정다운
한협우
김명준
장민정
백성환
Original Assignee
(주)튜링겐코리아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020160158685A external-priority patent/KR101904216B1/en
Priority claimed from KR1020160158684A external-priority patent/KR101904215B1/en
Application filed by (주)튜링겐코리아 filed Critical (주)튜링겐코리아
Publication of WO2018097388A1 publication Critical patent/WO2018097388A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to a composition containing jujube seed extract, and more particularly to cosmetics, pharmaceutical compositions and foods for skin whitening, wrinkle improvement, antioxidant and sunscreen containing jujube seed extract as an active ingredient. It relates to a composition.
  • the eyes, hair, and skin color of a person are determined by the concentration and distribution of melanin in the skin, and also by the type of melanin, but are also affected by various environmental and physiological factors such as ultraviolet rays and stress.
  • Melanin is a series of enzymatic enzymes that begins by oxidizing tyrosine, a type of amino acid in melanocytes in the basal layer of the epidermis, into oxidized by merosinase tyrosinase in the melanocytes of melanocytes. Produced through oxidation and non-enzymatic oxidation.
  • melanin is a representative influence factor, ultraviolet rays, and other genetic factors, environmental factors, hormones, foods, pharmaceuticals and other chemicals. This melanin absorbs a certain amount of ultraviolet light to protect the skin and maintain body temperature, but when severely irritated, over-produced melanin deposits, causing freckles, senile spots, blemishes, brown or sunspots, sunburn, and wounds. Alternatively, hyperpigmentation and phototoxic reactions may occur after inflammation due to dermatitis.
  • inhibitory activity against tyrosinase such as hydroquinone, ascorbic acid, kojic acid, glutathione and cysteine has been used.
  • hydroquinone exhibits a predetermined whitening effect, but has a problem of limiting the amount of the compound to a very small amount due to severe skin irritation.
  • Ascorbic acid is easily oxidized, causing problems such as discoloration and discoloration.
  • the manufacturing process of the cosmetic is complicated by the instability in the silver solution.
  • thiol-based compounds such as glutathione and cysteine not only have a characteristic unpleasant odor, but also have problems with transdermal absorption, and glycosides and derivatives thereof have high polarity, making it difficult to use as a component of a cosmetic composition.
  • vitamin C has a problem in that it is easily oxidized in the aqueous solution state does not have a lasting effect.
  • human skin color is determined by the concentration and distribution of melanin (melanin) inside the skin, in addition to genetic factors, it is also affected by environmental or physiological conditions such as solar ultraviolet rays, fatigue, stress.
  • Melanin is synthesized in melanocytes in the epidermal layer of the skin, and the enzyme tyrosinase acts on tyrosine, a type of amino acid, in the melanocytes (melanosome), the dopa (DOPA) and dopaquinone. It is produced by non-enzymatic oxidation.
  • tyrosinase acts on tyrosine, a type of amino acid, in the melanocytes (melanosome), the dopa (DOPA) and dopaquinone. It is produced by non-enzymatic oxidation.
  • Skin is an organ in which aging occurs primarily, and many studies have been conducted in the cosmetic field to delay or prevent it. Normally, skin aging begins about 25 years of age, and skin aging proceeds in earnest around 40 years of age. As a typical phenomenon of skin aging, sebum secretion is reduced, skin is dried, cell regeneration is slowed, and aging keratin is accumulated a lot of skin roughness. In addition, the amount of collagen that supports the epidermis is reduced, and elastin (elastic fiber) is denatured, resulting in wrinkles. In addition, the color of the skin stains, pigmentation symptoms such as blemishes, blotch, etc. appear, the epidermis becomes thinner and the skin protection function is weakened.
  • Collagenase belongs to the group of Matrix metalloproteinases (MMPs), which play an important role in matrix protein degradation.
  • MMPs Matrix metalloproteinases
  • the collagenase is known to be promoted by ultraviolet rays, growth factors, inflammatory cytokines, phorbol esters to break down collagen type 1, 2, 3, 5, especially in the ultraviolet It is known to play a major role in photoaging.
  • metalloproteinases may contain type 4 collagen fibers (MMP-2, -3), elastic fibers (MMP-2), or substrate proteins such as fibronectin or laminin (MMP-3). It can be observed that there is a marked increase in expression in aged skin. Therefore, the development of materials that can reduce the activity of metalloproteinases is actively made.
  • DEJ dermal epidermal junction
  • elastin fibers form crosslinks with collagen and are important skin components in the production of wrinkles involved in skin elasticity.
  • Deficiency and aggregation of elastin fibers and a dramatic increase in the activity of elastase, an elastin degrading enzyme, have been found to be one of the causes of skin wrinkles.
  • Elastase is the only enzyme that can break down elastin and its inhibition is known to fundamentally reduce skin wrinkles.
  • Human skin is composed of the epidermis, the dermis, and connective tissue including the stratum corneum, of which the dead layer consists of dead cell layers formed through the differentiation of keratinocytes, the basal cells of the epidermis. It protects the human body from the influence of the external environment.
  • UV A About 90% of the ultraviolet light that reaches the earth's surface is UV A and less than 10% is UV B.
  • the wavelength of the light is inversely proportional to the energy, so the absolute amount of UVB at least has a strong energy, which can affect the cell's genes.
  • the minimum amount of light that a particular wavelength of light causes erythema on the skin is called the minimal erythema dose (MED).
  • MED minimal erythema dose
  • the minimum amount of erythema of the skin is 50-70 J / cm2 for UV A and 50-70 mJ / cm2 for UV B, and 1 / 1,000 of UV A can cause erythema.
  • the minimum amount of UV B erythema in hairless mice used in skin barrier studies varies from report to report, but is approximately 20-80 mJ / cm 2 .
  • Ultraviolet rays can cause skin cancer by altering DNA, and are unwelcome in the skin enough to suppress skin immune responses by reducing the number of cells responsible for skin immunity. Due to the increased awareness of UV rays, sunscreen and absorption related cosmetics have been developed in various formulations and types.
  • the jujube seed is a seed part in the flesh of the jujube and is a jujube processing by-product generated after processing the jujube pulp.
  • Jujube seed by-products produced during jujube processing account for about 30% of the weight of jujube.
  • Jujube is often added to sweeten like licorice in oriental medicine, and has its own pharmacological effect to improve the symptoms of gastric cramps, insomnia, indigestion, intestinal hemorrhage, blue blood, and hypersensitivity.
  • Jujube seed has high nutritional value due to its high content of protein, minerals and fiber, and has been used as a herbal medicine called Sanjoin in Chinese medicine. Despite these excellent nutritional and pharmacological values, most jujube seed resources are not industrially utilized and are discarded.
  • Jujube seeds contain fatty oils consisting mainly of unsaturated fatty acids of oleic acid and linoleic acid, as well as saponins, eblin and lactone.
  • medicinal ingredients betulin, betulicacid and the like are known, and as medicinal ingredients of jujube, various sterols, alkaloids, vitamins, saponins, serotonin, fatty acids, polyphenols, flavonoids and the like are known.
  • the cyclic-AMP component is about 1,000 times higher than the general plant, and other nutrients such as sugars and organic acids are known (Ministry of food and drug safety, 2013).
  • the present inventors have continued to develop new natural substances having skin whitening, anti-wrinkle, anti-oxidant and sunscreen effects and less human side effects, and jujube seed extract has excellent skin whitening effect without cytotoxicity,
  • the present invention has been completed by discovering the fact that the anti-wrinkle effect as well as the anti-wrinkle effect and antioxidant effect are exhibited.
  • the technical problem to be solved by the present invention is to provide a material having excellent human safety while having skin whitening, wrinkle improvement, antioxidant and sunscreen effect.
  • the present invention provides a composition for skin whitening, anti-wrinkle, antioxidant and sunscreen, comprising jujube seed extract as an active ingredient.
  • the composition comprising the jujube seed extract in the present invention may be a cosmetic composition, a pharmaceutical composition or a food composition.
  • extract refers to a formulation prepared by squeezing the herbal medicine with a suitable leach solution and evaporating the leach solution, but not limited thereto, but the extract obtained by the extraction treatment, the dilution or concentrate of the extract, the extract It may be a dried product obtained by drying, these adjustment products, or a refined product.
  • Jujube seed extract of the present invention can be extracted using a conventional extraction solvent known in the art, the extracted liquid can be used in liquid form or concentrated and / or dried.
  • the extraction solvent is, for example, (a) water, (b) anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms (methanol, ethanol, propanol, butanol, etc.), (c) the lower alcohol and water A mixed solvent, (d) acetone, (e) ethyl acetate, (f) chloroform or (g) 1,3-butylene glycol can be obtained as an extraction solvent.
  • the extraction is performed using methanol, ethanol or butane.
  • the extraction degree and loss degree of the active ingredient of the extract may vary, so select an appropriate extraction solvent.
  • the extraction method is not particularly limited, and examples thereof include cold needle extraction, ultrasonic extraction, reflux cooling extraction, and the like.
  • the jujube seed extract may be obtained through a conventional purification process in addition to the extraction by the extraction solvent. Obtained by various additional purification methods, such as separation using an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatography (manufactured for separation according to size, charge, hydrophobicity or affinity). Jujube seed extract can also be obtained through the fraction.
  • the jujube seed extract is prepared by pulverizing the jujube seed using a solvent selected from the group consisting of an extraction solvent, such as water, anhydrous or hydrous lower alcohol having 1 to 3 carbon atoms, and a mixed solvent thereof. It can be extracted, the amount of the extraction solvent may be 2 to 20 weight times, preferably 5 to 15 weight times the dry weight of the herbal medicine.
  • the jujube seed extract is recovered after being deposited for 20 to 30 hours, preferably 22 to 26 hours, using 20 to 95% aqueous ethanol solution, preferably 50 to 70% aqueous ethanol solution. Then, filtered through filter paper and concentrated to obtain a jujube seed extract.
  • the composition of the present invention may include the jujube seed extract in 0.005 to 50% by weight, more preferably 0.01 to 30% by weight, most preferably 0.1 to 10% by weight based on the total weight of the composition.
  • the content of jujube seed extract is less than 0.005% by weight, the skin whitening effect and the wrinkle improvement effect, which are the objective effects of the present invention, cannot be obtained, and when the content exceeds 50% by weight, the effect is not proportional to the increase of the content. It may be inefficient and there is a problem in that formulation stability is not secured.
  • composition containing the jujube seed extract of the present invention exhibits skin whitening, anti-wrinkle, anti-oxidant and sunscreen effects, and has little cytotoxicity as a natural substance.
  • a cosmetic composition comprising the jujube seed extract as an active ingredient.
  • Cosmetic compositions according to one embodiment of the present invention include ingredients commonly added to cosmetic compositions in addition to jujube seed extract as active ingredients, such as conventional auxiliaries such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavors, and Carriers may be further added.
  • auxiliaries such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavors, and Carriers may be further added.
  • the cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing , Oils, powder foundations, emulsion foundations, wax foundations and sprays, and the like, but are not limited thereto. More specifically, it may be prepared in the form of a nourishing cream, astringent lotion, a flexible lotion, a lotion, an essence, a nourishing gel or a massage cream.
  • the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracant gum, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide are used as carrier components.
  • animal oil, vegetable oil, wax, paraffin, starch, tracant gum, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide are used as carrier components.
  • animal oil vegetable oil, wax, paraffin, starch, tracant gum, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide
  • tracant gum cellulose derivative
  • polyethylene glycol silicone
  • bentonite silica
  • talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as the carrier component when the formulation of the present invention is a powder or a spray, and in particular in the case of a spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.
  • a solvent, solubilizer or emulsifier is used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 Fatty acid esters of, 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
  • liquid carrier diluents such as water, ethanol or propylene glycol
  • suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Castle cellulose, aluminum metahydroxy, bentonite, agar or tracant gum can be used.
  • the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, an isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide.
  • Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
  • the pharmaceutical composition according to one embodiment of the present invention comprises a pharmaceutically acceptable carrier in addition to the jujube seed extract.
  • Pharmaceutically acceptable carriers included in the pharmaceutical compositions of the present invention are those commonly used in the preparation of lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, calcium phosphate, alginate, gelatin, Calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, and the like It doesn't happen.
  • the pharmaceutical composition of the present invention may further include a lubricant, a humectant, a sweetener, a flavoring agent, an emulsifier, a suspending agent, a preservative, and the like.
  • a lubricant e.g., talc, kaolin, kaolin, kaolin, kaolin, kaolin, kaolin, kaolin, kaolin, kaolin, a kaolin, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, mannitol, mannitol, mannitol, mannitol, mannitol, mannitol, mannitol, mannitol, mannitol, mann
  • the pharmaceutical composition of the present invention may be administered orally or parenterally, and is preferably applied by topical application by parenteral administration, more preferably by application.
  • Suitable dosages of the pharmaceutical compositions of the present invention vary depending on factors such as the formulation method, mode of administration, age, weight, sex, morbidity, food, time of administration, route of administration, rate of excretion and response to response of the patient. Can be.
  • the dosage of the pharmaceutical composition of the present invention is in the range of 0.001-100 mg / kg on an adult basis.
  • the dosage does not limit the scope of the present invention.
  • compositions of the present invention may be prepared in unit dosage form or in multidose form by formulating with a pharmaceutically acceptable carrier and / or excipient, according to methods which can be easily carried out by those skilled in the art. It may be prepared by incorporation into a container.
  • the formulation may be in the form of a solution, suspension, syrup or emulsion in an oil or an aqueous medium, or may be in the form of an exir, powder, powder, granule, tablet or capsule, and may further include a dispersing or stabilizing agent.
  • the food composition according to one embodiment of the present invention contains not only jujube seed extract as an active ingredient, but also components commonly added in food preparation, such as proteins, carbohydrates, fats, nutrients, seasonings and flavoring agents. It may further comprise.
  • Such carbohydrates are monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose, oligosaccharides and the like; And sugars such as conventional sugars such as polysaccharides such as dextrin, cyclodextrin and the like and xylitol, sorbitol, erythritol.
  • natural flavoring agents tauumatin, stevia extract (for example rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used.
  • the food composition of the present invention is prepared with a drink
  • citric acid liquid fructose, sugar, glucose, acetic acid, malic acid, fruit juice, tofu extract, jujube extract, licorice extract, etc. may be further included.
  • the present invention provides a method and its use for obtaining a skin whitening and wrinkle improvement effect of a subject by administering to the subject a composition comprising a jujube seed extract as an active ingredient.
  • the present invention provides a method and use thereof for obtaining an antioxidant and sunscreen effect of a subject by administering to the subject a composition comprising a jujube seed extract as an active ingredient.
  • the present invention is to improve the skin condition of the individual by administering a composition comprising jujube seed extract as an active ingredient to the subject to enhance the skin whitening, wrinkle improvement, antioxidant and sunscreen effect of the subject It provides a method and its use.
  • composition to be administered to the subject of the present invention has the effect of improving the skin condition of the subject or a disease, disease or abnormality caused by them due to skin whitening, wrinkle improvement, antioxidant and sunscreen effects as described above.
  • the term "individual” refers to monkeys, cows, horses, pigs, sheep, dogs, cats, rats, mice, chimpanzees, including humans with skin conditions whose symptoms can be improved by administering the composition of the invention. It means a mammal such as.
  • the term "improvement” means (a) suppression of (a) development, (b) alleviation, and (c) removal of pigmentation, skin aging, wrinkle formation, skin disease or inflammatory disease caused by ultraviolet rays in a subject. do.
  • jujube seed extract of the present invention is a natural substance, harmless to the human body, has little toxicity and side effects, so can be used safely even in long-term use, in particular can be safely applied to cosmetics, pharmaceutical and food compositions as described above .
  • the composition comprising the jujube seed extract of the present invention as an active ingredient has a tyrosinase inhibitory effect and not only have a whitening effect, but also have an anti-wrinkle effect by inhibiting elastase and collagenase activity.
  • the DPPH free radical, ABST radical cation, hydrogen peroxide and superoxide anion radical scavenging activity is excellent and has an antioxidant effect, the cell is not killed by irradiation with ultraviolet light can be usefully used as a sunscreen agent.
  • the jujube seed extract of the present invention is excellent in antibacterial activity, there is no cytotoxicity and skin side effects can be used safely in cosmetics, pharmaceutical and food compositions.
  • 1 is a graph showing the tyrosinase activity inhibitory effect of jujube seed extract.
  • 2 is a graph showing the inhibitory effect of DOPA oxidation inhibitory activity of jujube seed extract.
  • Figure 3 is a graph showing the elastase inhibitory activity according to the concentration of ethanol as the extract solvent of jujube seed extract.
  • Figure 4 is a graph showing the collagenase inhibitory activity according to the concentration of ethanol, the extract solvent of jujube seed extract.
  • 5 is a graph showing the results of DPPH electron donating ability according to the concentration of ethanol as an extract solvent of jujube seed extract.
  • Figure 6 is a graph showing the ABTS radical scavenging ability according to the concentration of ethanol, the extraction solvent of jujube seed extract.
  • H 2 O 2 hydrogen peroxide
  • 9 and 10 are photographs showing the antimicrobial activity of the jujube seed extract against microorganisms.
  • Figure 11 shows the cell viability of jujube seed extract.
  • FIG. 12 is a graph showing the protective effect of jujube seed extract against UVB-induced apoptosis in HaCaT cells.
  • Figure 13 is a graph showing the effect on the expression of MMP-2 and MMP-9 of jujube seed extract.
  • 14 is a graph showing the effect of jujube seed extract on UV-irradiated Pro-Collagen Type 1 and MMP-2 and MMP-9 expression.
  • Figure 15 is a graph showing the measurement of the pH change of the sunscreen formulation according to the jujube seed extract content.
  • Figure 16 is a graph showing the viscosity change of the sunscreen formulation according to the jujube seed extract content.
  • Jujube seed extract used in this experiment was used to crush the one provided from Mae Nam Nongsan (Cheongdo, Gyeongbuk). 1000 ml of 20%, 40%, 60% 80%, 95% ethanol was immersed in 1 kg of sample for 24 hours, and then collected three times. Filtered with 2 filter paper, the filtrate was concentrated using a vacuum rotary concentrator, lyophilized, and used in the experiment while storing at -20 °C.
  • Tyrosinase inhibition activity was measured using the dopachrome method.
  • the reaction zone was reacted for 15 minutes at 37 ° C by adding 10 ul of mushroom tyrosinase (2,000U / mL) to a mixture of 10 ul of substrate solution dissolved in 11.5 mM L-tyrosine in 110 ul of 0.1 M phosphate buffer (pH 6.5) and 10 ul of sample solution. It measured at 490 nm.
  • DOPA oxidation inhibition activity was measured by the absorbance decrease rate of the sample solution added and no added solution.
  • Tyrosinase (monophenol, dihydroxy-L-phenylalanin: oxygen oxidoreductase, EC 1.14.18.1) is a copper-containing enzyme in L-tyrosine, the initial stage of melanin synthesis, in L-3,4-dihydroxyphenylalanine (DOPA), in DOPA. It acts on the transition to L-dopaquinone. Ultraviolet mitosis of melanocytes occurs followed by melanocyte activation. In activated melanocytes, tyrosinase synthesis is promoted and melanin is produced and transported out of the epidermis, causing pigmentation such as blemishes and freckles.
  • DOPA L-3,4-dihydroxyphenylalanine
  • tyrosine activity inhibitors can effectively inhibit the synthesis of melanin polymer in the skin.
  • Tyrosinase activity inhibition experiments have been recognized as useful evaluation methods in the development of skin whitening agents. Therefore, tyrosinase plays an important role in melanin biosynthesis process, so tyrosinase inhibitors can be used as substances that can control melanin pigmentation of skin.
  • tyrosinase inhibitors such as 4-hydroxyanisole and hydroquinone have been used to treat hyper-pigmentation in humans, and have been reported to be effective in inhibiting the proliferation of melanoma cells.
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is a jujube seed extract extracted with 95% ethanol
  • arbutin was used as a positive control.
  • DOPA oxidation inhibition activity was measured according to the method of Yagi et al.
  • the reaction zone was added with 0.2 mL of mushroom tyrosinase (110U / mL) in a mixture of 0.2 mL of substrate solution dissolved in 10 mM L-DOPA in 0.5 mL of 1/15 M sodium phosphate buffer (pH 6.8) and 0.1 mL of sample solution.
  • DOPA chrome produced in the reaction solution was measured at 475 nm.
  • DOPA oxidation inhibition activity was measured by the absorbance decrease rate of the sample solution added and no added solution.
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is a jujube seed extract extracted with 95% ethanol
  • arbutin was used as a positive control.
  • J60 showed an inhibitory activity of 52.4% at a concentration of 500 ug / mL, and it was confirmed that DOPA inhibited the transfer to L-dopaquinone.
  • Elastase inhibitory activity was measured as follows. The extract was prepared at a constant concentration, 0.5 mL each was taken in a test tube, 0.5 mL of porcine pancreas elastase (2.5 U / mL) solution dissolved in 50 mM tris-HCl buffer (pH 8.6) was added, followed by 50 mM tris-HCl buffer (pH). Substrate N-succinyl- (L-Ala) 3-p-nitroanilide (0.5 mg / mL) dissolved in 8.6) was added and reacted for 20 minutes, and the amount of p-nitroanilide produced from the substrate was measured at 405 nm. Elastase inhibitory activity was expressed by the absorbance reduction rate of the sample solution added and the group added.
  • Matrix -metalloproteinases induced by UV light and free radicals in the dermal layer of skin are closely related to skin aging, especially wrinkle formation.
  • Main components of MMPs include collagenase, gelatinase, and elastase, and elasticity and moisture are decreased due to internal and external stress such as ultraviolet rays, and the elastin network structure is increased due to overexpressed elastase.
  • the skin sags and wrinkles, so the reduction of the elastase activity is very important in reducing the elasticity of the skin and wrinkles.
  • Elastase which hydrolyzes elastin, is an enzyme associated with skin wrinkles and the effect of jujube seed extract on elastase activity was observed.
  • Figure 3 is a graph showing the elastase inhibitory activity according to the concentration of ethanol as the extract solvent of jujube seed extract.
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is a jujube seed extract extracted with 95% ethanol
  • ursolic acid was used as a positive control.
  • ursolic acid showed a concentration-dependent inhibition of elastase
  • jujube seed extract showed a slight inhibition at 60% ethanol, but other extracts in the experimental concentration showed little inhibition.
  • Collagenase inhibitory activity was measured as follows. In other words, 4 mM CaCl 2 was added to 0.1 M tris-HCl buffer (pH 7.5) and 0.25 mL of substrate solution in which 4-phenylazobenzyl oxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (0.3 mg / mL) was dissolved. 0.15 mL of collagenase (0.2 mg / mL) was added to a 0.1 mL mixture of the sample solution, and the mixture was allowed to stand at room temperature for 20 minutes. Then, 0.5 mL of 6% citric acid was added to stop the reaction. Then, 1.5 mL of ethyl acetate was added thereto. Absorbance was measured at 320 nm. Collagenase inhibitory activity was expressed by the decrease in absorbance of the sample solution added and non-added.
  • Collagenase shows the elasticity of connective tissue, constitutes more than 90% of the dermis, has wrinkles and moisturizing function of the skin, and decreases biosynthesis with age.
  • Figure 4 is a graph showing the collagenase inhibitory activity according to the concentration of ethanol, the extract solvent of jujube seed extract.
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is the jujube seed extract extracted with 95% ethanol
  • EGCG Epigallocatechin gallate as a positive control.
  • the result of measuring the collagenase inhibitory activity of jujube seed extract showed the highest inhibitory activity of 30.7% of J60 at a concentration of 1,000ug / ml.
  • Electron donating ability was measured according to Blois's method (1958). 1 mL of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl (DPPH) was added to 2 mL of each sample solution, stirred for 30 minutes, and the absorbance was measured at 517 nm. The electron donating ability was expressed as the absorbance decrease rate of the sample solution added group and the group without addition.
  • DPPH 1,1-diphenyl-2-picrylhydrazyl
  • DPPH radical scavenging ability is a kind of measuring electron donating ability. The higher the reducing power, the more powerful the antioxidant. Based on the reduction of DPPH, it is possible to estimate the reducing power and antioxidant power of the measured substance.
  • DPPH electron donating ability to inhibit oxidation by donating electrons of free radicals in the chain reaction of lipid peroxidation was measured by adjusting and adding the jujube seed extract to a concentration of 10-1,000 ug / ml.
  • FIG. 5 is a graph showing the results of DPPH electron donating ability according to the concentration of ethanol as an extract solvent of jujube seed extract.
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is a jujube seed extract extracted with 95% ethanol
  • BHA is a butylated hydroxyanisole as a positive control.
  • ABTS radical cation scavenging ability becomes distinctive index blue green when ABTS + radical is formed by reaction of 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) with potassium persulfate.
  • ABTS 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
  • the addition of hydrogen donating antioxidants and chain breaking antioxidants is a measure of decolorization to light green as added.
  • Antioxidant activity using ABTS radical was measured by ABTS + cation decolorization assay method (Roberta, et al., 1999). 7 mM 2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) and 2.4 mM potassium persulfate were mixed for 24 hours in a dark room at room temperature to form ABTS +, diluted with ethanol, and sampled in 0.1 mL ABTS +. 0.1 mL was added and allowed to stand for 1 minute, and then the absorbance was measured at 732 nm.
  • Figure 6 is a graph showing the ABTS radical scavenging ability according to the concentration of ethanol, the extraction solvent of jujube seed extract.
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is a jujube seed extract extracted with 95% ethanol
  • BHA is a butylated hydroxyanisole as a positive control.
  • jujube seed ABTS radical cation scavenging ability was measured 44.56% activity at a concentration of 100 ug / ml, it was excellent effect of 99.38% at 500 ug / ml. This result is similar to that of the control group BHA, and thus, it is judged that the possibility of industrialization as a natural antioxidant is very high as the DPPH effect.
  • Hydrogen peroxide (H 2 O 2 ) inhibitory activity was determined by hydrogen peroxide analysis (Jayaprakasha et al., 2004). After 1.0 mL of sample solution and 2.0 mL of 40 mM hydrogen peroxide solution dissolved in phosphate-buffer saline (PBS, pH 7.4) were reacted at 37 ° C. for 10 minutes, the absorbance was measured at 230 nm for the amount of hydrogen peroxide inhibited in the reaction solution. . We compared the activity with synthetic antioxidant BHA.
  • Hydrogen peroxide inhibitory activity measurement is one of the most useful methods of measuring the ability of antioxidants to reduce the content of prooxidants such as hydrogen peroxide.
  • Hydrogen peroxide is a weak oxidant and is known to directly reduce the activity of some enzymes by oxidizing the thiol group, an essential group of enzymes.
  • Hydrogen peroxide is also important because it is a reactive, non-radical substance that can pass directly through the biofilm. Hydrogen peroxide is converted into highly reactive singlet oxygen and hydroxyl radicals through various reactions through biofilms to induce lipid peroxidation or toxicity in cells.
  • H 2 O 2 hydrogen peroxide
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is a jujube seed extract extracted with 95% ethanol
  • BHA is a butylated hydroxyanisole as a positive control.
  • the inhibitory activity of the jujube seed extract was increased depending on the concentration of hydrogen peroxide. Among them, 60% ethanol extract showed similar activity as the positive control.
  • Superoxide anion radical scavenging ability was measured by NBT reduction method according to Fridovich's method. To 1 ml of each sample solution and 0.4 ml of 0.1 M potassium phosphate buffer (pH 7.5), add 1 ml of xanthine (0.4 mM) and NBT (0.24 mM), and add 1 ml of xanthine oxidase (0.2 U / ml). After reacting at 37 ° C. for 20 minutes, 1 ml of 1 N HCl was added to terminate the reaction. Then, the amount of superoxide anion radical generated in the reaction solution was measured at 560 nm.
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is a jujube seed extract extracted with 95% ethanol
  • BHA is a butylated hydroxyanisole as a positive control.
  • the jujube seed extract showed about 20% superoxide anion radical scavenging activity at all concentrations.
  • Candida in a liquid medium for the culture of the albicans (KCTC 7965) it was used as the YM broth (YMB), Escherichia Nutrient broth (NB) was used for the liquid medium of coli (KCTC 1039) and Staphylococcus epidermidis (KCTC 1917), tryptic soy broth (TSB) was used for the liquid medium of Staphylococcus aureus (KCTC 1621), and Propionibacterium acnes (KCTC) was used.
  • GAM and solid medium was used by adding agar to the liquid medium. Strains were cultured by growth temperature in a BOD incubator.
  • Antibacterial activity was measured using a paper disc method.
  • each strain cultured on a plate medium with 1 platinum incubated for 18-24 hours in 10 mL of liquid medium, dissolved in 0.85% saline and mixed well, and then adjusted to 0.5 McFarland turbidity (spectrophotometer, 530 nm), and the concentration of the strain was about 1-5X10. 6 CFU / mL.
  • the sterilized swabs were evenly spread on MH-GMB medium, and the disc and antibiotic (control) discs prepared with jujube seed extract in concentration-dependent manner were loaded. The diameter of the clear zone (mm) around the disc was measured by incubating at 37 ° C for 18-24 hours. The results are shown in FIGS. 5 and 6.
  • FIG and 10 are photographs showing the antimicrobial activity of the jujube seed extract against microorganisms.
  • J20 is jujube seed extract extracted with 20% ethanol
  • J40 is jujube seed extract extracted with 40% ethanol
  • J60 is jujube seed extract extracted with 60% ethanol
  • J80 is jujube seed extract extracted with 80% ethanol
  • J95 is a jujube seed extract extracted with 95% ethanol.
  • CCRF S-180 II (Mouse skin fibroblast cell line, KCLB No. 10008) was distributed from Korean Cell Line Bank (Seoul, Korea).
  • Cell culture medium was used Dulbecco's modified Eagle's medium (DMEM).
  • 10% fetal bovine serum (FBS), 100 U / ml penicillin (100 U / ml), and 100 mg / ml streptomycin (100 mg / ml) were added.
  • Subculture was used 0.05% trypsin, 0.53 mM EDTA.
  • Toxicity of jujube cells was analyzed by MTT assay method. This method measures the conversion of mitochondrial dehydrogenases into formazan by dispensing CCRF S-180 II (Mouse skin fibroblast cells) of 1X 10 4 cells / well in 96 well plates and extracting 60% ethanol extract of jujube seeds by concentration (62.5). ⁇ 1000 ug / ml) was incubated for 24 hours. 20 ul of MTT solution per well was added and reacted for 4 hours at 37 ° C. 5% CO 2 , and then the absorbance change was measured at 490 nm using a microplate reader to express cell viability as a percentage.
  • CCRF S-180 II Mae fibroblast cells
  • Figure 11 shows the cell viability of jujube seed extract. As shown here, the cell viability was 97.9% at the concentration of 200 ug / ml.
  • UV rays When UV rays are irradiated to the skin cells, the UV rays directly or indirectly damage the cell structure by directly inducing DNA structure changes or oxidative reactions.
  • UVB was irradiated to the cells to kill the cells, and using the sample to determine the extent of inhibition of cell death, UVB was examined and treated with MTT reagent to confirm the degree of cell death.
  • HaCaT cells Human Keratynocyte Cells
  • DMSO Thiozolyl Blue Tetra-zolium Bromide
  • FIG. 12 is a graph showing the protective effect of jujube seed extract against UVB-induced apoptosis in HaCaT cells. As shown here, the addition of the jujube seed extract after irradiation with ultraviolet rays shows the result of increasing the survival of the cells, which can be said that the jujube seed extract is effective in suppressing the aging phenomenon.
  • Gelatin zymography was performed to investigate the effect of jujube seed extract on MMP-2 and MMP-9 activity using the properties of MMP-2 and MMP-9, which degrades gelatin.
  • Gelatin Zymography was used to investigate the effect of jujube seed on the expression level of MMP-2 and MMP-9.
  • 10% SDS-polyacrylamide gel (30% acrylamide / 0.8% bis-acrylamide, 1.5M Tris-HCl (pH8.8), 10% SDS, 10% APS, TEMED, 0.2% Gelatin, DW
  • the buffer was mixed 1: 1 and electrophoresed.
  • Figure 13 is a graph showing the effect on the expression of MMP-2 and MMP-9 of jujube seed extract. As shown here, it can be seen that the expression level of MMP-2 and MMP-9 increased in the section treated with UVB (50mJ / cm 2 ). Thus, when treated with 60% extract of jujube seed EtOH by concentration, 50 ug / ml treatment did not show a change in expression, but the concentration-dependent MMP-2 and MMP- in the section treated with 100 ug / ml, 200 ug / ml It was confirmed that the expression level of 9 decreases.
  • the jujube seed extract was treated by concentration, cells were collected, washed with PBS, dissolved in RIPA buffer (M.biotek) for 1 hour, and then centrifuged at 12,000rpm and 4 ° C for 10 minutes. Was recovered. The recovered supernatant was denatured at 90 ° C. for 10 minutes by adding SDS sample buffer (M.biotek), and proteins were separated by molecular weight by SDS-PAGE. The isolated protein was transferred to nitrocellulose membrane (Whatman, UK) for 1 hour at 100V, blocked with 0.1% BSA solution, and the membrane was immersed in Antibody solution for 18 hours at 4 °C.
  • FIG. 14 is a graph showing the effect of jujube seed extract on UV-irradiated Pro-Collagen Type 1 and MMP-2 and MMP-9 expression.
  • the UVB irradiation decreased, and the positive control group and J60 increased in a concentration dependent manner.
  • MMP-9 it was confirmed that MMP-9 suppressed the visible expression level.
  • a sunscreen formulation was prepared according to the content of jujube seed extract (hereinafter referred to as "HC-Phytoju”) as shown in Table 1 below.
  • Phase Trade Name HC-A HC-B HC-C A phase D.I-water up to 100 up to 100 up to 100 Disodium EDTA Q.S Q.S Q.S 1.2-Hexandiol Q.S Q.S Q.S MgSO4 Q.S Q.S Q.S 1,3-BG Q.S Q.S Q.S D.P.G Q.S Q.S Q.S HC-Phytoju 1.00 3.00 5.00 B phase Parsol mcx Q.S Q.S Q.S Parsol ehs Q.S Q.S Q.S Neoheliopan E1000 Q.S Q.S Q.S HallBrite BHB Q.S Q.S Q.S Finoslov TN Q.S Q.S Q.S Vit.E Acetate Q.S Q.S Q.S C phase KF 995 Q.S Q.S Q.S Bentone 38V Q.S Q.S Q.S D phase KF 995 Q.S Q.S Q.S DC 200 / 6
  • pH measurement was performed using a pH meter of Ohaus (Starter 3100F). Before the measurement, the glass electrode was immersed in basic buffer or distilled water for several hours, and the pH meter was connected to a power source and left for 10 minutes or more. The detector was washed well with water and wiped lightly before use.
  • Figure 15 is a graph showing the measurement of the pH change of the sunscreen formulation according to the jujube seed extract content. As shown here, the pH of the sunscreen stored at 25 ° C. for 12 weeks on days 0, 1, 3, 5, 7, 14, 28, 60 and 90 was measured, and the prescription HC-A, HC-B and HC- In the C formulation, slight differences in pH values were observed depending on the content of the jujube seed extract during the storage period.
  • Viscosity measurements were measured using a Brookfield Viscometer (Brookfield LV-II +, Brookfield Engineering Laboratories Inc., Middleboro, MA, USA). In order to reduce the effect of the bubble was measured by minimizing the factors that can affect the viscosity value by defoaming during manufacture.
  • the viscosity of the sunscreen stored at 25 ° C. was selected at spindle No. 4 for 1 minute at 12 rpm. The viscosity was measured for 12 weeks on the 0, 1, 3, 5, 7, 15, 30, 60, and 90 days.
  • Figure 16 is a graph showing the viscosity change of the sunscreen formulation according to the jujube seed extract content.
  • the viscosity of the sunscreen stored at 25 ° C. for 12 weeks on days 0, 1, 3, 5, 7, 14, 28, 60, and 90 was measured.
  • prescription HC-A, HC-B and HC- C All formulations showed a difference in viscosity to 26,000-17,500 cps for 3 months, and especially in the case of HC-B and HC-C formulations, a decrease in viscosity was observed during the storage period.
  • the sunscreen is placed in a transparent container and stored at 0 ° C., 25 ° C. and 45 ° C. for 12 weeks, respectively, and evaluated for stability at temperatures up to 0, 1, 3, 5, 7, 15, 30, 60, and 90 days. Temperature stability was evaluated to investigate chemical and physical changes caused by spontaneous deterioration of sunscreen over time. At high temperature (45 °C), the effect was observed on rancidity, discoloration, discoloration, flotation, sedimentation, separation, etc., and at the low temperature, physical and chemical changes such as coagulation, precipitation, and separation were observed.
  • the sunscreen prepared for each prescription was placed in a transparent container and stored for 12 weeks at 0 ° C, 25 ° C and 45 ° C, respectively, and evaluated for stability by temperature until the 1st, 3, 5, 7, 14, 28, 60 and 90 days. 2 (0 ° C), Table 3 (25 ° C) and Table 4 (45 ° C) show the stability results over time, respectively.
  • the sunscreen (HC-A, HC-B, HC-C) stored at 0 °C was observed to be stable for 28 days without the phenomenon of creaming or aggregation, but stored at 25 °C in Table 3
  • B was 28 days
  • C was 14 days
  • B was 14 days and C was 7 days after the sunscreen stored at 45 °C. Creaming and flocculation occurred, resulting in instability.
  • the stability test method according to the temperature cycle (Cycle chamber) is carried out to observe the change of physical properties according to the storage conditions of low and high temperature of cosmetics in Korea with four distinct seasons, and also the change of physical properties in emulsification and solubilization according to temperature change. To observe. Most of the products are hydrolysis and other phenomena occur quickly at high temperatures, and at low temperatures, volume expansion, interfacial membrane damage due to solubility difference, and precipitation occur.
  • the stability test by the cycle chamber can check this phenomenon in a short period of time. The results are shown in Table 5 below.
  • the test was conducted on the subject and the like.
  • the test site was selected to avoid skin damage, excessive hairs or areas of particular color tone and was clean and dry.
  • UV artificial irradiator Multiport solar simulator 601, V2.5 Solar Light, USA
  • the instrument is equipped with a 300watt Xenon arc lamp, which has a continuous emission spectrum similar to sunlight and does not exhibit a specific peak, as the light source is irradiated with a dichroic mirror and aiming lens. After passing through a collimating lens, the liquid is emitted in a square size of 0.8 cm X 0.8 cm through six liquid light guides. Special filters are used to remove wavelengths in the ultraviolet region below 290 nm, which are particularly harmful to humans.
  • Light intensity meter in units of ⁇ W / cm 2 measured by combining the SUV probe at the end of each light guide, and confirm that the measured value is maintained before and after UV irradiation.
  • Sunscreen index evaluation test of 12 subjects was conducted at the Korean Dermatological Research Institute, a cosmetic clinical research institute, and the sunscreen index averaged 50.5 ⁇ 2.3. could be confirmed.
  • standard samples were prepared and tested at the same time according to the test method suggested by the Ministry of Food and Drug Safety, and the UV protection index of 15.3 ⁇ 1.3 was confirmed.
  • the 95% confidence intervals of the UV protection index of each of the standard sample and the test sample measured through this test were confirmed to be within ⁇ 20% of the measured value, thereby verifying the reliability of the measured value.
  • the product is considered to have ultraviolet power equivalent to SPF 50.5 ⁇ 2.3.
  • the composition comprising the jujube seed extract of the present invention as an active ingredient has a tyrosinase inhibitory effect and not only have a whitening effect, but also have an anti-wrinkle effect by inhibiting elastase and collagenase activity.
  • the DPPH free radical, ABST radical cation, hydrogen peroxide and superoxide anion radical scavenging activity is excellent and has an antioxidant effect, the cell is not killed by irradiation with ultraviolet light can be usefully used as a sunscreen agent.
  • the jujube seed extract of the present invention is excellent in antibacterial activity, there is no cytotoxicity and skin side effects can be used safely in cosmetics, pharmaceutical and food compositions.

Abstract

The present invention relates to a composition containing a Jujube seed extract. The composition, of the present invention, containing a Jujube seed extract as an active ingredient has a whitening effect by having an effect of inhibiting tyrosinase and has a wrinkle alleviation effect by inhibiting the activity of elastase and collagenase. In addition, the composition has an antioxidative effect by having an excellent scavenging activity for DPPH free radicals, ABTS radical cations, hydrogen peroxide, and superoxide anion radicals and prevents cell death caused by ultraviolet ray irradiation, thereby being useful as an ultraviolet ray blocking agent. Furthermore, the Jujube seed extract of the present invention has an excellent antibacterial activity, is noncytotoxic, and has no skin side effects, and thus can be safely used in cosmetic, pharmaceutical, and food compositions for skin whitening, wrinkle alleviation, antioxidation, and ultraviolet light blocking.

Description

대추씨 추출물을 유효성분으로 포함하는 피부미백, 주름개선, 항산화 및 자외선차단을 위한 조성물Composition for skin whitening, wrinkle improvement, antioxidant and sunscreen comprising jujube seed extract as an active ingredient
본 발명은 대추씨(Jujube seed) 추출물을 함유하는 조성물에 관한 것으로, 보다 구체적으로는 대추씨 추출물을 유효성분으로 함유하는 피부미백, 주름개선, 항산화 및 자외선차단을 위한 화장료, 약학적 조성물 및 식품 조성물에 관한 것이다. The present invention relates to a composition containing jujube seed extract, and more particularly to cosmetics, pharmaceutical compositions and foods for skin whitening, wrinkle improvement, antioxidant and sunscreen containing jujube seed extract as an active ingredient. It relates to a composition.
일반적으로 사람의 눈동자, 머리 및 피부색은 피부 내 멜라닌의 농도와 분포에 따라 결정되기도 하고, 멜라닌의 종류에 따라서도 달라지기도 하지만, 자외선이나 스트레스 등 다양한 환경 및 생리적인 요소들에 의해서도 영향을 받는다. 멜라닌은 표피의 기저층에 존재하는 멜라닌세포(melanocyte)에서 아미노산의 일종인 티로신이 멜라닌 세포의 멜라노좀에서 티로시나아제(tyrosinase)에 의해 도파로 산화되어 도파크롬으로 전환되는 것을 시작으로 계속되는 일련의 효소적 산화과정 및 비효소적 산화과정을 거쳐 생성된다. 이런 멜라닌의 생성과 합성에는 대표적인 영향인자로 자외선이 있고, 그 밖에도 유전적 요인과 환경적 요인, 호르몬, 식품, 의약품 등의 화학물질 등이 작용한다. 이러한 멜라닌은 일정량의 자외선을 흡수하여 피부를 보호하고 체온을 유지해주는 역할을 하지만, 심한 자극을 받게 될 경우 과생성된 멜라닌이 침착되어 주근깨, 노인성 반점, 기미, 갈색 또는 흑점, 일광 색소반, 상처 또는 피부염으로 인한 염증 후 과색소침착, 광독성 반응 등이 일어날 수 있다.Generally, the eyes, hair, and skin color of a person are determined by the concentration and distribution of melanin in the skin, and also by the type of melanin, but are also affected by various environmental and physiological factors such as ultraviolet rays and stress. Melanin is a series of enzymatic enzymes that begins by oxidizing tyrosine, a type of amino acid in melanocytes in the basal layer of the epidermis, into oxidized by merosinase tyrosinase in the melanocytes of melanocytes. Produced through oxidation and non-enzymatic oxidation. The production and synthesis of melanin is a representative influence factor, ultraviolet rays, and other genetic factors, environmental factors, hormones, foods, pharmaceuticals and other chemicals. This melanin absorbs a certain amount of ultraviolet light to protect the skin and maintain body temperature, but when severely irritated, over-produced melanin deposits, causing freckles, senile spots, blemishes, brown or sunspots, sunburn, and wounds. Alternatively, hyperpigmentation and phototoxic reactions may occur after inflammation due to dermatitis.
최근 동양권 여성들은 하얗고 깨끗한 피부를 선호하며, 이를 미의 중요한 기준으로 삼고 있기 때문에 피부색소 이상침착의 치료 및 미용욕구 충족을 위한 미백제에 대한 개발이 활발히 이루어지고 있다. 현재 피부미용을 위한 미백제의 개발에 있어서, 생성된 멜라닌 색소를 환원시켜 탈색하는 방법과 멜라닌 색소를 형성하는 효소인 티로시나제의 활성을 억제하는 방법이 알려져 있다. 그러나 멜라닌 색소를 환원시키기 위해 사용되는 토코페롤이나 비타민류 등을 사용한 미백제는 멜라닌 색소의 탈색효과가 미미한 것으로 알려져 있으므로 멜라닌 색소의 생성을 억제하는 저해제에 관한 연구가 다수 진행되고 있다.Recently, Asian women prefer white and clean skin, and this is an important criterion of beauty. Therefore, the development of whitening agents for the treatment of abnormal skin pigmentation and the fulfillment of beauty needs has been actively made. At present, in the development of a whitening agent for skin beauty, a method of reducing the generated melanin pigment by decolorization and a method of inhibiting the activity of tyrosinase, an enzyme that forms melanin pigment, are known. However, since whitening agents using tocopherols and vitamins used to reduce the melanin pigment are known to have a slight decolorizing effect of the melanin pigment, many studies have been conducted on inhibitors that inhibit the production of melanin pigment.
종래에는 피부미백이나 피부 과색소 침착증을 개선하기 위하여, 히드로퀴논(hydroquinone), 아스콜빈산(ascorbic acid), 코직산(kojic acid), 글루타치온(glutathione) 및 시스테인(cysteine)과 같은 티로시나제에 대해 저해 활성을 갖는 물질을 사용하여 왔다. 그러나, 히드로퀴논은 소정의 미백효과를 발휘하지만 피부자극성이 심하여 배합량을 극소량으로 제한해야 하는 문제점이 있고, 아스콜빈산은 산화되기 쉬워 이를 배합한 화장료의 경우 변색, 변취되는 등의 문제가 발생하며, 코직산은 용액 내에서 불안전하여 화장료의 제조공정이 복잡해진다는 단점이 있다. 또한, 글루타치온 및 시스테인 등의 티올계 화합물은 특유의 불쾌한 냄새를 가질 뿐만 아니라 경피흡수에도 문제점이 있고, 이들의 배당체 및 유도체들도 극성이 높으므로 화장료의 배합 성분으로 사용하기는 어렵다. 그 외에 비타민 C의 경우 수용액 상태에서 쉽게 산화되어 지속적인 효과를 내지 못하는 문제점이 있다.In order to improve skin whitening or hyperpigmentation, conventionally, inhibitory activity against tyrosinase such as hydroquinone, ascorbic acid, kojic acid, glutathione and cysteine Has been used. However, hydroquinone exhibits a predetermined whitening effect, but has a problem of limiting the amount of the compound to a very small amount due to severe skin irritation. Ascorbic acid is easily oxidized, causing problems such as discoloration and discoloration. There is a disadvantage that the manufacturing process of the cosmetic is complicated by the instability in the silver solution. In addition, thiol-based compounds such as glutathione and cysteine not only have a characteristic unpleasant odor, but also have problems with transdermal absorption, and glycosides and derivatives thereof have high polarity, making it difficult to use as a component of a cosmetic composition. In addition, vitamin C has a problem in that it is easily oxidized in the aqueous solution state does not have a lasting effect.
한편, 사람의 피부색은 피부 내부의 멜라닌(melanin) 농도와 분포에 따라 결정되는데, 유전적인 요인 외에도, 태양 자외선이나 피로, 스트레스 등의 환경적 또는 생리적 조건에 의해서도 영향을 받는다. 멜라닌은 피부 표피층에 있는 멜라노사이트에서 합성되는데, 멜라노사이트 내 소기관인 멜라노좀(melanosome)에서 아미노산의 일종인 티로신(tyrosine)에 티로시나제(tyrosinase)라는 효소가 작용하여 도파(DOPA), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어진다. 이와 같은 멜라닌의 합성이 피부 내에서 과도하게 일어나면, 피부 톤을 어둡게 하고, 기미, 주근깨 등을 발생시킨다. 따라서, 피부 내의 티로시나제 활성을 저해하여 멜라닌 색소의 합성을 저해시키면, 피부 톤을 밝게 하여 피부미백을 실현할 수 있을 뿐만 아니라 자외선, 호르몬 및 유전적인 원인에 기인하여 발생하는 기미, 주근깨 등의 피부 과색소 침착증을 개선시킬 수 있다.On the other hand, human skin color is determined by the concentration and distribution of melanin (melanin) inside the skin, in addition to genetic factors, it is also affected by environmental or physiological conditions such as solar ultraviolet rays, fatigue, stress. Melanin is synthesized in melanocytes in the epidermal layer of the skin, and the enzyme tyrosinase acts on tyrosine, a type of amino acid, in the melanocytes (melanosome), the dopa (DOPA) and dopaquinone. It is produced by non-enzymatic oxidation. When such synthesis of melanin occurs excessively in the skin, the skin tone is darkened, and the appearance of spots, freckles, and the like. Therefore, by inhibiting the synthesis of melanin pigment by inhibiting the tyrosinase activity in the skin, not only can brighten the skin tone to realize skin whitening, but also hyperpigmentation of skin such as blemishes and freckles caused by ultraviolet rays, hormones and genetic causes Can improve deposition.
피부는 노화가 일차적으로 나타나는 기관으로 이를 지연 또는 예방하기 위하여 화장품 영역에서도 많은 연구가 진행되어 왔다. 통상적으로 피부노화는 25세를 전후하여 진행되기 시작하여 40세를 전후한 시기에 본격적으로 피부노화가 진행된다. 피부노화의 대표적 현상으로 피지 분비량이 감소되어 피부가 건조해지고, 세포 재생이 늦어지고, 노화 각질이 많이 쌓여서 피부가 거칠어지는 특징이 있다. 또한, 표피를 지탱해주는 콜라겐의 합성양이 감소되고 엘라스틴(탄력섬유)이 변성되어 주름이 생긴다. 아울러, 피부색이 얼룩지거나 기미, 검버섯 등의 색소 침착 증상이 나타나며, 표피가 얇아져서 피부보호 기능이 약화된다. 그 밖의 현상으로는 피부 두께의 감소와 관련된 피부 장벽작용(Barrier Effect)의 저하로 인한 피부 트러블의 증가를 들 수 있다. 피부노화와 관련된 연구는 크게 피부노화의 주요원인이 되는 자외선과 활성산소로부터 피부를 보호하는 소재, 피부주름개선 소재, 피부탄력 증진 소재, 피부 표피와 진피 접합부(Dermal-Epidermal Junction, DEJ) 강화에 관련된 소재로 분류하여 심도 깊게 연구되고 있다.Skin is an organ in which aging occurs primarily, and many studies have been conducted in the cosmetic field to delay or prevent it. Normally, skin aging begins about 25 years of age, and skin aging proceeds in earnest around 40 years of age. As a typical phenomenon of skin aging, sebum secretion is reduced, skin is dried, cell regeneration is slowed, and aging keratin is accumulated a lot of skin roughness. In addition, the amount of collagen that supports the epidermis is reduced, and elastin (elastic fiber) is denatured, resulting in wrinkles. In addition, the color of the skin stains, pigmentation symptoms such as blemishes, blotch, etc. appear, the epidermis becomes thinner and the skin protection function is weakened. Other phenomena include an increase in skin problems due to a decrease in the barrier effect associated with a decrease in skin thickness. Research on skin aging is mainly focused on strengthening skin dermal-epidermal junction (DEJ), which protects the skin from UV rays and free radicals, which are the main causes of skin aging, skin wrinkle improvement materials, skin elasticity enhancing materials. In-depth study by classifying related materials.
피부에 노화가 진행되면 진피의 변화가 현저하게 나타나며, 70세 이후 나타나는 진피위축은 대표적인 노화현상이다. 진피의 변화는 섬유아세포(fibroblast)의 숫자와 이들의 합성 능력의 감소로 인하여 세포 외 기질 중 큰 분자량을 가진 물질들의 변화로 발생된다. 그 구체적인 변화는 콜라겐 다발의 분리, 점다당질 합성감소, 콜라겐과 탄력섬유(elastin) 수와 직경 감소, 콜라겐과 탄력섬유 분해 및 혈관의 팽창 등을 들 수 있다. 일반적으로 피부의 수분 함유량, 콜라겐 함유량 및 외부 환경에 대한 면역 작용 능력 등 여러 가지 복합적인 요인들 중 주름의 형성에 가장 큰 영향을 미치는 것은 콜라겐의 생성량과 콜라겐의 함량을 감소시키는 콜라겐 분해 효소인 콜라게네이즈의 발현량과 활성이다. 콜라게네이즈는 기질단백질 분해에 중요한 역할을 하는 금속단백분해효소(Matrix metalloproteinases, MMPs) 그룹에 속한다. 이러한 콜라게네이즈는 자외선, 성장인자, 염증성 사이토카인, 포르볼 에스테르(phorbol ester)에 의해 발현이 촉진되어 제1,2,3,5형 교원질(collagen)을 분해하는 것으로 알려져 있으며, 특히 자외선에 의한 광노화에 주요한 역할을 담당하는 것으로 알려져 있다. 그 밖에 금속단백분해효소(MMPs)는 4형 교원섬유(MMP-2,-3), 탄력섬유(MMP-2), 또는 피브로넥틴(fibronectin)이나 라미닌(laminin, MMP-3)과 같은 기질단백질을 분해하며, 노화된 피부에서 발현이 현저히 증가됨을 관찰할 수 있다. 따라서 금속단백분해효소의 활성을 감소시킬 수 있는 소재개발이 활발하게 이루어지고 있다.As the skin ages, the changes in the dermis appear remarkably, and dermis atrophy after 70 years is a representative aging phenomenon. Changes in the dermis are caused by changes in substances with large molecular weight in the extracellular matrix due to a decrease in the number of fibroblasts and their ability to synthesize. Specific changes include separation of collagen bundles, reduced point polysaccharide synthesis, decreased collagen and elastic fiber counts and diameters, collagen and elastic fiber degradation, and blood vessel dilation. Generally, among the various factors such as skin moisture content, collagen content, and ability to immunize the external environment, the biggest influence on wrinkle formation is collagen, a collagen degrading enzyme that reduces collagen production and collagen content. It is the expression level and activity of genease. Collagenase belongs to the group of Matrix metalloproteinases (MMPs), which play an important role in matrix protein degradation. The collagenase is known to be promoted by ultraviolet rays, growth factors, inflammatory cytokines, phorbol esters to break down collagen type 1, 2, 3, 5, especially in the ultraviolet It is known to play a major role in photoaging. In addition, metalloproteinases (MMPs) may contain type 4 collagen fibers (MMP-2, -3), elastic fibers (MMP-2), or substrate proteins such as fibronectin or laminin (MMP-3). It can be observed that there is a marked increase in expression in aged skin. Therefore, the development of materials that can reduce the activity of metalloproteinases is actively made.
또한, 노화가 진행되면 피부진피뿐 아니라 진피와 표피 부착을 담당하는 DEJ(Dermal epidermal junction) 단백질 역시 발현이 감소하면서 표피-진피 접합부가 평평해지고 연결이 약해져 피부가 쉽게 손상을 받게 된다. DEJ가 약화되면 표피와 진피의 원활한 커뮤니케이션이 이루어지지 않아 피부재생이 원활히 이루어지지 않는다. 최근 연구결과에 따르면 DEJ가 주름과 피부장벽 뿐 아니라 자외선 자극에 의한 피부색소 침착에도 관련하고 있다고 알려져 있다(Iriyama S, J Dermatol Sci. 64(3):223-228, 2011). 진피 접합부에는 라미닌-5(laminin-5), 콜라겐-Ⅳ(collagen-IV), 콜라겐 Ⅶ(collagen Ⅶ)이 존재하고 이들 단백질 발현을 증가시킬 수 있는 소재는 피부주름을 개선시킬 수 있다.In addition, as aging progresses, the dermal epidermal junction (DEJ) protein, which is responsible for the attachment of the dermis and the epidermis, also decreases in expression, and the epidermal-dermal junction is flattened and the connection is weak. When DEJ is weakened, skin and epidermis cannot communicate smoothly and skin regeneration is not performed smoothly. Recent studies have shown that DEJ is involved not only in wrinkles and skin barriers but also in skin pigmentation due to UV stimulation (Iriyama S, J Dermatol Sci. 64 (3): 223-228, 2011). Laminin-5, collagen-IV, and collagen VII are present at the dermal junction, and materials capable of increasing the expression of these proteins can improve skin wrinkles.
또한, 엘라스틴(elastin) 섬유는 콜라겐과 가교 결합을 형성하며 피부 탄력에 관여하고 있는 주름 생성에 중요한 피부 구성성분이다. 엘라스틴 섬유의 결핍과 응집, 엘라스틴 분해 효소인 엘라스타제(elastase)의 활성도의 현격한 증가는 피부 주름생성 요인 중의 하나로 밝혀지고 있다. 엘라스타제는 엘라스틴을 분해할 수 있는 유일한 효소로서 이에 대한 저해는 피부 주름개선을 근본적으로 줄여줄 수 있다고 알려져 있다.In addition, elastin fibers form crosslinks with collagen and are important skin components in the production of wrinkles involved in skin elasticity. Deficiency and aggregation of elastin fibers and a dramatic increase in the activity of elastase, an elastin degrading enzyme, have been found to be one of the causes of skin wrinkles. Elastase is the only enzyme that can break down elastin and its inhibition is known to fundamentally reduce skin wrinkles.
사람의 피부는 각질층을 포함하는 표피와 진피, 그리고 결합조직으로 구성되어 있는데, 그 중 각질층은 표피(epidermis)의 기저세포인 케라티노사이트(keratinocyte)의 분화과정을 통해 형성되는 죽은 세포층으로 구성되어 있고 인체를 외부환경의 영향으로부터 보호해주는 역할을 담당하고 있다. 이러한 피부에서의 노화의 원인에 대해서는 크게 두 가지로 연구되고 있는데, 하나는 "내적 노화"로서 연령의 증가에 따른 피부의 구성단위인 세포의 기능변화에 기인한 것이고, 다른 하나는 "외적 노화"로서 외부 환경 즉 자외선, 공해, 스트레스 등에 의한 것으로 나눌 수 있다.Human skin is composed of the epidermis, the dermis, and connective tissue including the stratum corneum, of which the dead layer consists of dead cell layers formed through the differentiation of keratinocytes, the basal cells of the epidermis. It protects the human body from the influence of the external environment. There are two major researches on the causes of aging in the skin. One is "internal aging," which is caused by a change in the function of cells, which are components of the skin, with age, and the other is "external aging." As a result, it can be divided into external environment, ie, ultraviolet light, pollution, and stress.
피부의 세포는 생체 내에서 필요한 에너지 공급을 위해 인간의 생체 내에서 필요한 에너지 공급을 위해 끊임없이 일어나는 생화학 반응에서 발생하는 활성산소종에 의해 산화적 스트레스가 가해지게 되면, 세포 구성 성분들인 지질, 단백질, 탄수화물과 DNA 산화적 손상 및 효소활성을 변화시켜 피부암 등의 각종 질병을 일으키는 원인이 되며, 노화를 촉진시킨다. When skin cells are subjected to oxidative stress by reactive oxygen species, which occur in a constantly occurring biochemical reaction to supply the energy needed in vivo, the constituents of lipids, proteins, Carbohydrates and DNA oxidative damage and changes in enzyme activity cause various diseases such as skin cancer, and promotes aging.
특히 여름이 길어지며 국내 자외선차단제품 시장은 2010년 3,320억원대에서 매년 꾸준한 성장을 기록하며 2014년 4,200억원대 규모이다. 데이터모니터의 연구 자료에 따르면 국내 자외선차단제 시장 규모는 2010년 3,320억원에서 2011년 3,570억원, 2012년 3,770억원, 2013년 3,980억원을 기록하며 연 평균 6.34%의 지속적 성장세를 이어왔다. 광노화의 위험이 알려지면서 자외선차단제는 사계절 필수품으로 자리 잡아가고 있지만 여전히 여름 시즌에 강세를 보이며 대표적인 계절상품으로 판매되고 있다.In particular, with the prolonged summer, the domestic sunscreen products market grew steadily from 330 billion won in 2010 to 420 billion won in 2014. According to the research data of the data monitor, the size of the domestic sunscreen market recorded KRW 34 billion in 2010, KRW 357 billion in 2011, KRW 377.7 billion in 2012, and KRW 398 billion in 2013, and the average annual growth rate was 6.34%. As the risk of photoaging is known, sunscreens are becoming a necessity for the four seasons, but they are still strong in the summer season and are sold as representative seasonal products.
지표면에 도달하는 자외선의 90% 정도는 자외선 A 이며 10% 미만이 자외선 B 이다. 광선의 파장은 에너지와 반비례하므로 비록 자외선B가 절대량은 적어도 강한 에너지를 갖고 있으므로 세포의 유전자에 영향을 미칠 수 있다. 특정 파장대의 광선이 피부에 홍반을 유발하는 최소 광량을 최소 홍반량 (minimal erythema dose, MED)이라고 한다. 동양인에서 피부의 최소 홍반량은 자외선 A의 경우 50-70 J/cm2, 자외선 B의 경우 50-70 mJ/cm2이며 자외선 A의 1/1,000 량으로도 홍반을 일으킬 수 있다. 피부 장벽 연구에 많이 사용하는 hairless마우스에서 자외선 B의 최소 홍반량은 보고마다 차이가 있으나 대략 20-80 mJ/cm2정도이다. About 90% of the ultraviolet light that reaches the earth's surface is UV A and less than 10% is UV B. The wavelength of the light is inversely proportional to the energy, so the absolute amount of UVB at least has a strong energy, which can affect the cell's genes. The minimum amount of light that a particular wavelength of light causes erythema on the skin is called the minimal erythema dose (MED). In Asians, the minimum amount of erythema of the skin is 50-70 J / cm2 for UV A and 50-70 mJ / cm2 for UV B, and 1 / 1,000 of UV A can cause erythema. The minimum amount of UV B erythema in hairless mice used in skin barrier studies varies from report to report, but is approximately 20-80 mJ / cm 2 .
자외선은 DNA를 변화시켜 피부암을 일으킬 수 있으며 피부의 면역을 담당하는 세포의 수를 저하 시켜 피부 면역반응을 억제할 만큼 피부에 있어서 반갑지 않은 존재이다. 자외선에 대한 인식의 증가로 인하여 자외선차단 및 흡수 관련 화장품은 다양한 제형과 종류로 개발되고 있다.Ultraviolet rays can cause skin cancer by altering DNA, and are unwelcome in the skin enough to suppress skin immune responses by reducing the number of cells responsible for skin immunity. Due to the increased awareness of UV rays, sunscreen and absorption related cosmetics have been developed in various formulations and types.
따라서, 화장품 분야에서는 피부미백 및 주름개선, 항산화 및 자외선차단효과를 가지는 기능성 화장품에 대한 연구 및 개발이 활발하게 진행되고 있으며, 특히 피부에 독성이나 자극을 주지 않기 위하여 천연 물질을 이용한 연구가 계속되고 있다.Therefore, in the cosmetics field, research and development of functional cosmetics having skin whitening and wrinkle improvement, antioxidant and sunscreen effects are being actively conducted, and in particular, researches using natural materials to avoid toxicity or irritation to the skin continue. have.
한편, 대추씨는 대추의 과육 안에 있는 종자부위로써 대추 과육의 가공 후 생성되는 대추 가공 부산물이다. 대추 가공 시 생산되는 대추씨 부산물은 대추가공원료의 약 30% 중량을 차지한다. 예로부터 대추는 한방에서 감초처럼 감미를 내기 위해 첨가되는 경우가 많았고 그 자체로도 위경련, 불면증, 소화불량, 대장하혈, 청혈, 지각과민증의 증상을 개선시키는 약리효과가 있다. On the other hand, the jujube seed is a seed part in the flesh of the jujube and is a jujube processing by-product generated after processing the jujube pulp. Jujube seed by-products produced during jujube processing account for about 30% of the weight of jujube. Jujube is often added to sweeten like licorice in oriental medicine, and has its own pharmacological effect to improve the symptoms of gastric cramps, insomnia, indigestion, intestinal hemorrhage, blue blood, and hypersensitivity.
현재 대추의 잎과 열매는 식용이 가능하나 씨는 제한적으로 식용이 가능하다고 고시되어 있다. 대추씨는 단백질, 미네랄, 식이섬유 등의 함량이 높아 영양학적인 가치가 높고 한방에서는 산조인이라는 약재로도 사용되어져 왔다. 이러한 우수한 영양 및 약리학적인 가치에도 불구하고 대부분의 대추씨 자원은 산업적으로 활용되지 못하고 폐기되는 실정이다. At present, the leaves and fruits of the jujube are edible, but the seeds are limitedly edible. Jujube seed has high nutritional value due to its high content of protein, minerals and fiber, and has been used as a herbal medicine called Sanjoin in Chinese medicine. Despite these excellent nutritional and pharmacological values, most jujube seed resources are not industrially utilized and are discarded.
대추 종자의 성분으로는 주로 oleic acid, linoleic acid의 불포화 지방산으로 이루어진 지방유와 사포닌, eblin, lactone 등이 함유되어 있다. 약용성분으로는 betulin, betulicacid 등이 알려져 있으며, 대추의 약용성분으로는 각종 스테롤, 알칼로이드, 비타민, 사포닌, 세로토닌, 지방산, 폴리페놀, 플라보노이드 등이 알려져 있다. 특히 cyclic-AMP 성분은 일반식물보다 약 1,000배 이상 높은 함량을 나타내며 그 외 당류와 유기산 등의 영양성분이 알려져 있다(Ministry of food and drug safety, 2013).Jujube seeds contain fatty oils consisting mainly of unsaturated fatty acids of oleic acid and linoleic acid, as well as saponins, eblin and lactone. As medicinal ingredients, betulin, betulicacid and the like are known, and as medicinal ingredients of jujube, various sterols, alkaloids, vitamins, saponins, serotonin, fatty acids, polyphenols, flavonoids and the like are known. In particular, the cyclic-AMP component is about 1,000 times higher than the general plant, and other nutrients such as sugars and organic acids are known (Ministry of food and drug safety, 2013).
그러나, 아직까지 대추씨의 피부미백, 주름개선, 항산화 및 자외선차단효과에 관해서는 보고된 바가 없다.However, there have been no reports about the skin whitening, wrinkle improvement, antioxidant and sunscreen effects of jujube seeds.
이에 본 발명자들은 피부미백, 주름개선, 항산화 및 자외선차단효과를 가지면서 인체 부작용이 적은 새로운 천연물질을 개발하기 위해 계속 연구를 진행한 결과, 대추씨 추출물이 세포 독성이 없으면서도 우수한 피부미백 효과, 주름개선효과 및 항산화효과 뿐만 아니라 자외선차단효과를 나타낸다는 사실을 발견함으로써 본 발명을 완성하였다.Accordingly, the present inventors have continued to develop new natural substances having skin whitening, anti-wrinkle, anti-oxidant and sunscreen effects and less human side effects, and jujube seed extract has excellent skin whitening effect without cytotoxicity, The present invention has been completed by discovering the fact that the anti-wrinkle effect as well as the anti-wrinkle effect and antioxidant effect are exhibited.
따라서, 본 발명에서 해결하고자 하는 기술적 과제는 피부미백, 주름개선, 항산화 및 자외선차단효과를 가지면서 인체 안전성이 우수한 물질을 제공하기 위한 것이다.Therefore, the technical problem to be solved by the present invention is to provide a material having excellent human safety while having skin whitening, wrinkle improvement, antioxidant and sunscreen effect.
상기한 기술적 과제를 해결하기 위하여, 본 발명에서는 대추씨 추출물을 유효성분으로 포함하는 것을 특징으로 하는 피부미백, 주름개선, 항산화 및 자외선차단을 위한 조성물을 제공한다.In order to solve the above technical problem, the present invention provides a composition for skin whitening, anti-wrinkle, antioxidant and sunscreen, comprising jujube seed extract as an active ingredient.
바람직하게, 본 발명에서 대추씨 추출물을 포함하는 조성물은 화장료 조성물, 약학적 조성물 또는 식품 조성물일 수 있다.Preferably, the composition comprising the jujube seed extract in the present invention may be a cosmetic composition, a pharmaceutical composition or a food composition.
본 발명의 용어 "추출물(extract)"은 생약을 적절한 침출액으로 짜내고 침출액을 증발시켜 농축한 제제를 의미하는 것으로, 이에 제한되지는 않으나, 추출처리에 의해 얻어지는 추출액, 추출액의 희석액 또는 농축액, 추출액을 건조하여 얻어지는 건조물, 이들의 조정제물 또는 정제물일 수 있다. The term "extract" of the present invention refers to a formulation prepared by squeezing the herbal medicine with a suitable leach solution and evaporating the leach solution, but not limited thereto, but the extract obtained by the extraction treatment, the dilution or concentrate of the extract, the extract It may be a dried product obtained by drying, these adjustment products, or a refined product.
본 발명의 대추씨 추출물은 당분야에 공지된 통상적인 추출용매를 사용하여 추출할 수 있으며, 추출한 액은 액체 형태로 사용하거나 또는 농축 및/또는 건조하여 사용할 수 있다. 이 때, 상기 추출용매는 예를 들어, (a) 물, (b) 탄소수 1-4의 무수 또는 함수 저급 알코올(메탄올, 에탄올, 프로판올, 부탄올 등), (c) 상기 저급 알코올과 물과의 혼합용매, (d) 아세톤, (e) 에틸 아세테이트, (f) 클로로포름 또는 (g) 1,3-부틸렌글리콜을 추출 용매로 하여 수득할 수 있다. 바람직하게는, 메탄올, 에탄올 또는 부탄을 이용하여 추출하는 것이 좋다. 추출용매에 따라 추출물의 유효성분의 추출정도와 손실정도가 차이가 날 수 있으므로, 알맞은 추출용매를 선택하여 사용하도록 한다. 상기 추출 방법은 특별히 제한되지 않고, 예를 들어 냉침 추출, 초음파 추출, 환류 냉각 추출 등이 있다.Jujube seed extract of the present invention can be extracted using a conventional extraction solvent known in the art, the extracted liquid can be used in liquid form or concentrated and / or dried. At this time, the extraction solvent is, for example, (a) water, (b) anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms (methanol, ethanol, propanol, butanol, etc.), (c) the lower alcohol and water A mixed solvent, (d) acetone, (e) ethyl acetate, (f) chloroform or (g) 1,3-butylene glycol can be obtained as an extraction solvent. Preferably, the extraction is performed using methanol, ethanol or butane. Depending on the extraction solvent, the extraction degree and loss degree of the active ingredient of the extract may vary, so select an appropriate extraction solvent. The extraction method is not particularly limited, and examples thereof include cold needle extraction, ultrasonic extraction, reflux cooling extraction, and the like.
또한, 상기 대추씨 추출물은 상기 추출용매에 의하여 추출하는 방법 외에 통상적인 정제과정을 거쳐서도 수득할 수 있다. 예컨대, 일정한 분자량 컷-오프 값을 갖는 한외여과막을 이용한 분리, 다양한 크로마토그래피(크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제방법을 통해 얻어진 분획을 통하여서도 대추씨 추출물을 수득할 수 있다.In addition, the jujube seed extract may be obtained through a conventional purification process in addition to the extraction by the extraction solvent. Obtained by various additional purification methods, such as separation using an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatography (manufactured for separation according to size, charge, hydrophobicity or affinity). Jujube seed extract can also be obtained through the fraction.
본 발명의 실시양태에 따르면, 대추씨 추출물은 대추씨를 분쇄한 후 추출용매, 예컨대 물, 탄소수 1~3개의 무수 또는 함수 저급 알콜 및 이들의 혼합용매로 이루어진 군에서 선택된 용매를 추출용매로 사용하여 추출할 수 있으며, 상기 추출 용매의 양은 생약 건조 중량의 2 내지 20 중량배, 바람직하게는 5 내지 15 중량배로 할 수 있다.According to an embodiment of the present invention, the jujube seed extract is prepared by pulverizing the jujube seed using a solvent selected from the group consisting of an extraction solvent, such as water, anhydrous or hydrous lower alcohol having 1 to 3 carbon atoms, and a mixed solvent thereof. It can be extracted, the amount of the extraction solvent may be 2 to 20 weight times, preferably 5 to 15 weight times the dry weight of the herbal medicine.
본 발명의 하나의 구체적인 실시태양에서는, 대추씨 추출물은 20 내지 95% 에탄올 수용액, 바람직하게는 50 내지 70% 에탄올 수용액을 이용하여 20 내지 30시간, 바람직하게는 22 내지 26시간 동안 침적시킨 후 회수한 다음, 여과지로 여과하고 농축하여 대추씨 추출물을 수득할 수 있다.In one specific embodiment of the present invention, the jujube seed extract is recovered after being deposited for 20 to 30 hours, preferably 22 to 26 hours, using 20 to 95% aqueous ethanol solution, preferably 50 to 70% aqueous ethanol solution. Then, filtered through filter paper and concentrated to obtain a jujube seed extract.
본 발명의 조성물에는 대추씨 추출물이 조성물의 총 중량을 기준으로 하여 0.005 내지 50 중량%, 보다 바람직하게는 0.01 내지 30 중량%, 가장 바람직하게는 0.1 내지 10 중량%로 포함할 수 있다. 이 때 대추씨 추출물의 함량이 0.005 중량% 미만일 경우 본 발명의 목적효과인 피부미백 효과 및 주름개선효과를 수득할 수 없으며, 50 중량%를 초과할 경우 함량의 증가에 따라 효과가 비례적이지 않아 비효율적일 수 있으며 제형상의 안정성이 확보되지 않는 문제점이 있다.The composition of the present invention may include the jujube seed extract in 0.005 to 50% by weight, more preferably 0.01 to 30% by weight, most preferably 0.1 to 10% by weight based on the total weight of the composition. At this time, when the content of jujube seed extract is less than 0.005% by weight, the skin whitening effect and the wrinkle improvement effect, which are the objective effects of the present invention, cannot be obtained, and when the content exceeds 50% by weight, the effect is not proportional to the increase of the content. It may be inefficient and there is a problem in that formulation stability is not secured.
본 발명의 대추씨 추출물을 함유하는 조성물은 피부미백, 주름개선, 항산화 및 자외선차단효과를 나타내며, 천연 물질로서 세포독성이 거의 없다. The composition containing the jujube seed extract of the present invention exhibits skin whitening, anti-wrinkle, anti-oxidant and sunscreen effects, and has little cytotoxicity as a natural substance.
본 발명의 하나의 실시양태에 따르면, 대추씨 추출물을 유효성분으로 포함하는 화장료 조성물을 제공한다.According to one embodiment of the present invention, it provides a cosmetic composition comprising the jujube seed extract as an active ingredient.
본 발명의 하나의 실시양태에 따른 화장료 조성물에는 유효성분으로서의 대추씨 추출물 이외에 화장품 조성물에 통상적으로 첨가되는 성분, 예컨대 항산화제, 안정화제, 가용화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 및 담체를 추가로 첨가할 수 있다. Cosmetic compositions according to one embodiment of the present invention include ingredients commonly added to cosmetic compositions in addition to jujube seed extract as active ingredients, such as conventional auxiliaries such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavors, and Carriers may be further added.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 영양 크림, 수렴 화장수, 유연 화장수, 로션, 에센스, 영양젤 또는 마사지 크림의 제형으로 제조될 수 있다.The cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing , Oils, powder foundations, emulsion foundations, wax foundations and sprays, and the like, but are not limited thereto. More specifically, it may be prepared in the form of a nourishing cream, astringent lotion, a flexible lotion, a lotion, an essence, a nourishing gel or a massage cream.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트 검, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracant gum, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide are used as carrier components. Can be.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.Toss, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as the carrier component when the formulation of the present invention is a powder or a spray, and in particular in the case of a spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 가용화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 Fatty acid esters of, 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 검등이 이용될 수 있다.When the formulation of the present invention is a suspension, liquid carrier diluents such as water, ethanol or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Castle cellulose, aluminum metahydroxy, bentonite, agar or tracant gum can be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, an isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide. Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
본 발명의 하나의 실시양태에 따른 약학적 조성물은 대추씨 추출물 이외에 약학적으로 허용되는 담체를 포함한다. 본 발명의 약학적 조성물에 포함되는 약학적으로 허용되는 담체는 제제 시에 통상적으로 이용되는 것으로서, 락토스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 전분, 아카시아 고무, 인산 칼슘, 알기네이트, 젤라틴, 규산 칼슘, 미세결정성 셀룰로스, 폴리비닐피롤리돈, 셀룰로스, 물, 시럽, 메틸 셀룰로스, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 활석, 스테아르산 마그네슘 및 미네랄 오일 등을 포함하나, 이에 한정되는 것은 아니다. 본 발명의 약학적 조성물은 상기 성분들 이외에 윤활제, 습윤제, 감미제, 향미제, 유화제, 현탁제, 보존제 등을 추가로 포함할 수 있다. 적합한 약제학적으로 허용되는 담체 및 제제는 Remington's Pharmaceutical Sciences (19th ed., 1995)에 상세히 기재되어 있다.The pharmaceutical composition according to one embodiment of the present invention comprises a pharmaceutically acceptable carrier in addition to the jujube seed extract. Pharmaceutically acceptable carriers included in the pharmaceutical compositions of the present invention are those commonly used in the preparation of lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, calcium phosphate, alginate, gelatin, Calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, and the like It doesn't happen. In addition to the above components, the pharmaceutical composition of the present invention may further include a lubricant, a humectant, a sweetener, a flavoring agent, an emulsifier, a suspending agent, a preservative, and the like. Suitable pharmaceutically acceptable carriers and formulations are described in detail in Remington's Pharmaceutical Sciences (19th ed., 1995).
본 발명의 약학적 조성물은 경구 또는 비경구 투여할 수 있으며, 바람직하게는 비경구 투여, 보다 바람직하게는 도포에 의한 국부 투여(topical application) 방식으로 적용된다.The pharmaceutical composition of the present invention may be administered orally or parenterally, and is preferably applied by topical application by parenteral administration, more preferably by application.
본 발명의 약학적 조성물의 적합한 투여량은 제제화 방법, 투여 방식, 환자의 연령, 체중, 성별, 병적 상태, 음식, 투여 시간, 투여 경로, 배설 속도 및 반응 감응성과 같은 요인들에 의해 다양하게 처방될 수 있다. 본 발명의 약학적 조성물의 투여량은 성인 기준으로 0.001-100 ㎎/kg 범위 내이다. 또한 외용제인 경우에는 성인 기준으로 1.0 내지 3.0 ml의 양으로 1일 1회 내지 5회 도포하여 1개월 이상 계속 하는 것이 좋다. 다만, 상기 투여량은 본 발명의 범위를 한정하는 것이 아니다.Suitable dosages of the pharmaceutical compositions of the present invention vary depending on factors such as the formulation method, mode of administration, age, weight, sex, morbidity, food, time of administration, route of administration, rate of excretion and response to response of the patient. Can be. The dosage of the pharmaceutical composition of the present invention is in the range of 0.001-100 mg / kg on an adult basis. In addition, in the case of external preparations, it is recommended to continue the application for 1 month to 5 times a day in an amount of 1.0 to 3.0 ml on an adult basis. However, the dosage does not limit the scope of the present invention.
본 발명의 약학적 조성물은 당분야의 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 약학적으로 허용되는 담체 및/또는 부형제를 이용하여 제제화함으로써 단위 용량 형태로 제조되거나 또는 다용량 용기 내에 내입시켜 제조될 수 있다. 이 때 제형은 오일 또는 수성 매질중의 용액, 현탁액, 시럽제 또는 유화액 형태이거나 엑시르제, 산제, 분말제, 과립제, 정제 또는 캅셀제 형태일 수도 있으며, 분산제 또는 안정화제를 추가적으로 포함할 수 있다.The pharmaceutical compositions of the present invention may be prepared in unit dosage form or in multidose form by formulating with a pharmaceutically acceptable carrier and / or excipient, according to methods which can be easily carried out by those skilled in the art. It may be prepared by incorporation into a container. In this case, the formulation may be in the form of a solution, suspension, syrup or emulsion in an oil or an aqueous medium, or may be in the form of an exir, powder, powder, granule, tablet or capsule, and may further include a dispersing or stabilizing agent.
또한, 본 발명의 하나의 실시양태에 따른 식품 조성물에는 유효성분으로서 대추씨 추출물뿐만 아니라 식품 제조 시에 통상적으로 첨가되는 성분, 예를 들어, 단백질, 탄수화물, 지방, 영양소, 조미제 및 향미제를 추가로 포함할 수 있다.In addition, the food composition according to one embodiment of the present invention contains not only jujube seed extract as an active ingredient, but also components commonly added in food preparation, such as proteins, carbohydrates, fats, nutrients, seasonings and flavoring agents. It may further comprise.
상기 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스, 올리고당 등; 및 폴리사카라이드, 예를 들어 덱스트린, 사이클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 향미제로서 천연 향미제 [타우마틴, 스테비아 추출물 (예를 들어 레바우디오시드 A, 글리시르히진 등]) 및 합성 향미제(사카린, 아스파르탐 등)를 사용할 수 있다.Examples of such carbohydrates are monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose, oligosaccharides and the like; And sugars such as conventional sugars such as polysaccharides such as dextrin, cyclodextrin and the like and xylitol, sorbitol, erythritol. As the flavoring agent, natural flavoring agents (tauumatin, stevia extract (for example rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used.
예컨대, 본 발명의 식품 조성물이 드링크제로 제조되는 경우에는 본 발명의 대추씨 추출물 이외에 구연산, 액상과당, 설탕, 포도당, 초산, 사과산, 과즙, 두충 추출액, 대추 추출액, 감초 추출액 등을 추가로 포함시킬 수 있다.For example, when the food composition of the present invention is prepared with a drink, in addition to the jujube seed extract of the present invention, citric acid, liquid fructose, sugar, glucose, acetic acid, malic acid, fruit juice, tofu extract, jujube extract, licorice extract, etc. may be further included. Can be.
본 발명의 하나의 구체적 양태로, 본 발명은 대추씨 추출물을 유효성분으로 포함하는 조성물을 개체에 투여하여 개체의 피부미백 및 주름개선 효과를 얻기 위한 방법 및 그 용도를 제공한다.In one specific embodiment of the present invention, the present invention provides a method and its use for obtaining a skin whitening and wrinkle improvement effect of a subject by administering to the subject a composition comprising a jujube seed extract as an active ingredient.
본 발명의 하나의 구체적 양태로, 본 발명은 대추씨 추출물을 유효성분으로 포함하는 조성물을 개체에 투여하여 개체의 항산화 및 자외선차단 효과를 얻기 위한 방법 및 그 용도를 제공한다.In one specific embodiment of the present invention, the present invention provides a method and use thereof for obtaining an antioxidant and sunscreen effect of a subject by administering to the subject a composition comprising a jujube seed extract as an active ingredient.
본 발명의 하나의 구체적 양태로, 본 발명은 대추씨 추출물을 유효성분으로 포함하는 조성물을 개체에 투여하여 개체의 피부미백, 주름개선, 항산화 및 자외선차단 효과를 증진시켜 개체의 피부상태를 개선하는 방법 및 그 용도를 제공한다.In one specific embodiment of the present invention, the present invention is to improve the skin condition of the individual by administering a composition comprising jujube seed extract as an active ingredient to the subject to enhance the skin whitening, wrinkle improvement, antioxidant and sunscreen effect of the subject It provides a method and its use.
본 발명의 개체에 투여하는 조성물은 상술한 바와 같이 피부미백, 주름개선, 항산화 및 자외선차단 효과로 인하여 개체의 피부상태 또는 이들로부터 발생하는 질환, 질병 또는 이상을 개선시키는 효과가 있다. The composition to be administered to the subject of the present invention has the effect of improving the skin condition of the subject or a disease, disease or abnormality caused by them due to skin whitening, wrinkle improvement, antioxidant and sunscreen effects as described above.
본 발명에 있어서, 용어 "개체"는 본 발명의 상기 조성물을 투여하여 증상이 개선될 수 있는 피부상태를 가진 인간을 포함한 원숭이, 소, 말, 돼지, 양, 개, 고양이, 랫트, 마우스, 침팬지 등의 포유동물을 의미한다.In the present invention, the term "individual" refers to monkeys, cows, horses, pigs, sheep, dogs, cats, rats, mice, chimpanzees, including humans with skin conditions whose symptoms can be improved by administering the composition of the invention. It means a mammal such as.
본 발명에 있어서, 용어 "개선"은 개체에서 색소침착, 피부노화, 주름생성, 자외선에 의해 발생하는 피부질환 또는 염증질환의 (a) 발전의 억제, (b) 경감, (c) 제거를 의미한다.In the present invention, the term "improvement" means (a) suppression of (a) development, (b) alleviation, and (c) removal of pigmentation, skin aging, wrinkle formation, skin disease or inflammatory disease caused by ultraviolet rays in a subject. do.
한편, 본 발명의 대추씨 추출물은 천연물질로서 인체에 무해하며, 독성 및 부작용이 거의 없으므로 장기간 사용시에도 안심하고 사용할 수 있으며, 특히 상기한 바와 같은 화장료, 약학적 및 식품 조성물에 안전하게 적용할 수 있다.On the other hand, jujube seed extract of the present invention is a natural substance, harmless to the human body, has little toxicity and side effects, so can be used safely even in long-term use, in particular can be safely applied to cosmetics, pharmaceutical and food compositions as described above .
이와 같이, 본 발명의 대추씨 추출물을 유효성분으로 포함하는 조성물은 티로시나아제 저해효과를 가져 미백효과를 가질 뿐만 아니라 엘라스타제 및 콜라게나제 활성을 저해시킴으로써 주름개선효과를 가진다. 또한, DPPH 자유 라디칼, ABST 라디칼 양이온, 과산화수소 및 수퍼옥사이드 음이온 라디칼 소거활성이 우수하여 항산화 효과가 있으며, 자외선에 조사에 의해 세포가 사멸되지 않아 자외선차단제로서 유용하게 사용될 수 있다. 또한 본 발명의 대추씨 추출물은 항균 활성이 우수하고, 세포 독성 및 피부 부작용이 없어 화장료, 약학적 및 식품 조성물에 안전하게 사용할 수 있다. As such, the composition comprising the jujube seed extract of the present invention as an active ingredient has a tyrosinase inhibitory effect and not only have a whitening effect, but also have an anti-wrinkle effect by inhibiting elastase and collagenase activity. In addition, the DPPH free radical, ABST radical cation, hydrogen peroxide and superoxide anion radical scavenging activity is excellent and has an antioxidant effect, the cell is not killed by irradiation with ultraviolet light can be usefully used as a sunscreen agent. In addition, the jujube seed extract of the present invention is excellent in antibacterial activity, there is no cytotoxicity and skin side effects can be used safely in cosmetics, pharmaceutical and food compositions.
도 1은 대추씨 추출물의 티로시나제 활성억제 효과를 나타낸 그래프이다.1 is a graph showing the tyrosinase activity inhibitory effect of jujube seed extract.
도 2는 대추씨 추출물의 DOPA 산화 저해 활성억제 효과를 나타낸 그래프이다. 2 is a graph showing the inhibitory effect of DOPA oxidation inhibitory activity of jujube seed extract.
도 3은 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 엘라스타제 저해 활성을 나타낸 그래프이다.Figure 3 is a graph showing the elastase inhibitory activity according to the concentration of ethanol as the extract solvent of jujube seed extract.
도 4는 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 콜라게나제 저해 활성을 나타낸 그래프이다.Figure 4 is a graph showing the collagenase inhibitory activity according to the concentration of ethanol, the extract solvent of jujube seed extract.
도 5는 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 DPPH 전자공여능 결과를 나타낸 그래프이다.5 is a graph showing the results of DPPH electron donating ability according to the concentration of ethanol as an extract solvent of jujube seed extract.
도 6은 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 ABTS 라디칼 소거능을 나타낸 그래프이다.Figure 6 is a graph showing the ABTS radical scavenging ability according to the concentration of ethanol, the extraction solvent of jujube seed extract.
도 7은 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 과산화수소 (H2O2) 소거능을 나타낸 그래프이다.7 is a graph showing the hydrogen peroxide (H 2 O 2 ) scavenging ability according to the concentration of ethanol as an extract solvent of jujube seed extract.
도 8은 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 수퍼옥사이드 음이온 라디칼 소거능을 나타낸 그래프이다. 8 is a graph showing the superoxide anion radical scavenging ability according to the concentration of ethanol which is an extract solvent of jujube seed extract.
도 9 및 도 10은 대추씨 추출물의 미생물에 대한 항균 활성을 나타낸 사진이다. 9 and 10 are photographs showing the antimicrobial activity of the jujube seed extract against microorganisms.
도 11은 대추씨 추출물의 세포 생존율을 나타낸 것이다.Figure 11 shows the cell viability of jujube seed extract.
도 12는 HaCaT 세포에서 UVB로 인한 세포사멸에 대한 대추씨 추출물의 보호 효과를 나타낸 그래프이다. 12 is a graph showing the protective effect of jujube seed extract against UVB-induced apoptosis in HaCaT cells.
도 13은 대추씨 추출물의 MMP-2 및 MMP-9 발현에 미치는 영향을 나타낸 그래프이다. Figure 13 is a graph showing the effect on the expression of MMP-2 and MMP-9 of jujube seed extract.
도 14는 대추씨 추출물이 UVB 조사된 Pro-Collagen Type 1과 MMP-2 및 MMP-9 발현에 미치는 영향을 나타낸 그래프이다. 14 is a graph showing the effect of jujube seed extract on UV-irradiated Pro-Collagen Type 1 and MMP-2 and MMP-9 expression.
도 15는 대추씨 추출물 함량에 따른 선크림 제형의 pH 변화를 측정하여 나타낸 그래프이다.Figure 15 is a graph showing the measurement of the pH change of the sunscreen formulation according to the jujube seed extract content.
도 16은 대추씨 추출물 함량에 따른 선크림 제형의 점도 변화를 측정하여 나타낸 그래프이다. Figure 16 is a graph showing the viscosity change of the sunscreen formulation according to the jujube seed extract content.
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다. Hereinafter, examples and the like will be described in detail to help understand the present invention. However, embodiments according to the present invention can be modified in many different forms, the scope of the invention should not be construed as limited to the following examples. Embodiments of the present invention are provided to more fully describe the present invention to those skilled in the art.
<실시예 1> 대추씨 추출물 제조 Example 1 Preparation of Jujube Seed Extract
본 실험에 사용한 대추씨 추출물은 매남농산(경북 청도군)에서 제공 받은 것을 분쇄하여 사용하였다. 시료 1kg에 각각 20%, 40%, 60% 80%, 95% 에탄올 1000 ml을 24시간씩 침적시킨 후 3회 반복 회수하여 수집 후 No. 2 filter paper로 여과하여, 여액을 진공회전농축기를 사용하여 농축하고, 동결건조하였으며, -20℃에서 보관하면서 실험에 사용하였다.Jujube seed extract used in this experiment was used to crush the one provided from Mae Nam Nongsan (Cheongdo, Gyeongbuk). 1000 ml of 20%, 40%, 60% 80%, 95% ethanol was immersed in 1 kg of sample for 24 hours, and then collected three times. Filtered with 2 filter paper, the filtrate was concentrated using a vacuum rotary concentrator, lyophilized, and used in the experiment while storing at -20 ℃.
<시험예 1> 미백 효과 측정Test Example 1 Measurement of Whitening Effect
(1) 티로시나제(Tyrosinase) 저해활성 측정(1) Tyrosinase Inhibitory Activity
티로시나제 저해 활성 측정은 dopachrome 방법을 이용하여 측정하였다. 반응구는 0.1 M phosphate buffer (pH 6.5) 110 ul에 11.5 mM L-tyrosine을 녹인 기질액 10 ul 및 시료용액 10 ul 의 혼합액에 mushroom tyrosinase (2,000U/mL) 10 ul 첨가하여 37℃에서 15 분간 반응시켜 490nm에서 측정하였다. DOPA 산화 저해 활성 측정은 시료용액의 첨가구와 무 첨가구의 흡광도 감소율로 나타내었다.Tyrosinase inhibition activity was measured using the dopachrome method. The reaction zone was reacted for 15 minutes at 37 ° C by adding 10 ul of mushroom tyrosinase (2,000U / mL) to a mixture of 10 ul of substrate solution dissolved in 11.5 mM L-tyrosine in 110 ul of 0.1 M phosphate buffer (pH 6.5) and 10 ul of sample solution. It measured at 490 nm. DOPA oxidation inhibition activity was measured by the absorbance decrease rate of the sample solution added and no added solution.
티로시나제(monophenol, dihydroxy-L-phenylalanin : oxygen oxidore- ductase, EC 1.14.18.1)는 구리를 함유한 효소로서 melanin 합성의 초기단계인 L-tyrosine에서 L-3,4-dihydroxyphenylalanine (DOPA), DOPA에서 L-dopaquinone으로의 전이에 작용한다. 자외선에 의하여 melanocyte의 유사분열이 일어나고 이어서 melanocyte가 활성화된다. 활성화된 melanocyte 에서는 tyrosinase 합성이 촉진되고 melanin이 생성되어 이를 표피 밖으로 운반 배출하게 되어 기미, 주근깨와 같은 색소침착이 일어나게 된다. 그러므로 티로신 활성 억제제는 피부 내에서의 melanin polymer 합성을 효과적으로 저해할 수 있어 피부미백제의 개발에 있어서 티로시나제 활성억제 실험은 유용한 평가법으로 인정되고 있다. 따라서 티로시나제는 melanin 생합성 과정에서 중요한 역할을 하므로 티로시나제 억제제를 피부의 melanin 색소생성을 조절할 수 있는 물질로 사용할 수 있다. 또한 티로시나제 저해제인 4-hydroxyanisole, hydroquinone 등은 인체의 hyper-pigmentation 치료에 사용되고 있으며, melanoma cell의 증식억제에도 효과가 있는 것으로 보고되었다. Tyrosinase (monophenol, dihydroxy-L-phenylalanin: oxygen oxidoreductase, EC 1.14.18.1) is a copper-containing enzyme in L-tyrosine, the initial stage of melanin synthesis, in L-3,4-dihydroxyphenylalanine (DOPA), in DOPA. It acts on the transition to L-dopaquinone. Ultraviolet mitosis of melanocytes occurs followed by melanocyte activation. In activated melanocytes, tyrosinase synthesis is promoted and melanin is produced and transported out of the epidermis, causing pigmentation such as blemishes and freckles. Therefore, tyrosine activity inhibitors can effectively inhibit the synthesis of melanin polymer in the skin. Tyrosinase activity inhibition experiments have been recognized as useful evaluation methods in the development of skin whitening agents. Therefore, tyrosinase plays an important role in melanin biosynthesis process, so tyrosinase inhibitors can be used as substances that can control melanin pigmentation of skin. In addition, tyrosinase inhibitors such as 4-hydroxyanisole and hydroquinone have been used to treat hyper-pigmentation in humans, and have been reported to be effective in inhibiting the proliferation of melanoma cells.
도 1은 대추씨 추출물의 티로시나제 활성억제 효과를 나타낸 그래프이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이고, 알부틴(arbutin)을 양성 대조군으로 사용하였다.1 is a graph showing the tyrosinase activity inhibitory effect of jujube seed extract. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is a jujube seed extract extracted with 95% ethanol, and arbutin was used as a positive control.
도 1에서 보듯이, 대추씨 추출물의 미백효과 측정결과 Tysonise을 기질로 사용시 1,000 ug/mL의 농도에서도 15% 정도의 효과가 측정되었으며, 나머지 추출물도 미미하지만 22.8% ~ 31.7%의 저해활성을 나타내는 것을 확인하였다. As shown in Fig. 1, as a result of measuring the whitening effect of jujube seed extract, when Tysonise was used as a substrate, an effect of about 15% was measured even at a concentration of 1,000 ug / mL, and the rest of the extracts showed a slight inhibitory activity of 22.8% to 31.7%. It was confirmed.
(2) DOPA 산화 저해활성 측정(2) measurement of DOPA oxidation inhibitory activity
DOPA 산화 저해 활성 측정은 Yagi 등의 방법에 따라 측정하였다. 반응구는 1/15M sodium phosphate buffer (pH 6.8) 0.5mL에 10mM L-DOPA을 녹인 기질액 0.2mL및 시료용액 0.1mL의 혼합액에 mushroom tyrosinase (110U/mL) 0.2mL 첨가하여 25℃에서 2분간 반응시켜 반응액 중에 생성된 DOPA chrome을 475nm에서 측정하였다. DOPA 산화 저해 활성 측정은 시료용액의 첨가구와 무 첨가구의 흡광도 감소율로 나타내었다.DOPA oxidation inhibition activity was measured according to the method of Yagi et al. The reaction zone was added with 0.2 mL of mushroom tyrosinase (110U / mL) in a mixture of 0.2 mL of substrate solution dissolved in 10 mM L-DOPA in 0.5 mL of 1/15 M sodium phosphate buffer (pH 6.8) and 0.1 mL of sample solution. DOPA chrome produced in the reaction solution was measured at 475 nm. DOPA oxidation inhibition activity was measured by the absorbance decrease rate of the sample solution added and no added solution.
도 2는 대추씨 추출물의 DOPA 산화 저해 활성억제 효과를 나타낸 그래프이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이고, 알부틴(arbutin)을 양성 대조군으로 사용하였다.2 is a graph showing the inhibitory effect of DOPA oxidation inhibitory activity of jujube seed extract. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is a jujube seed extract extracted with 95% ethanol, and arbutin was used as a positive control.
도 2에서 보듯이, DOPA를 기질로 사용시 J60의 경우 500 ug/mL의 농도에서 52.4%의 저해활성을 나타내는 바, DOPA가 L-dopaquinone으로의 전이되는 것을 저해 하는 것을 확인할 수 있었다.As shown in FIG. 2, when DOPA was used as a substrate, J60 showed an inhibitory activity of 52.4% at a concentration of 500 ug / mL, and it was confirmed that DOPA inhibited the transfer to L-dopaquinone.
<시험예 2> 주름개선 효과 측정Test Example 2 Wrinkle Improvement Effect Measurement
(1) 엘라스타제(Elastase) 저해활성 측정(1) Determination of Elastase Inhibitory Activity
엘라스타제 저해활성 측정은 다음과 같이 측정하였다. 추출물을 일정 농도가 되도록 조제하여 0.5 mL씩 시험관에 취하고, 50 mM tris-HCl buffer (pH 8.6)에 녹인 porcine pancreas elastase (2.5 U/mL)용액 0.5 mL을 가한 후 50 mM tris-HCl buffer (pH 8.6)에 녹인 기질 N-succinyl-(L-Ala)3-p-nitroanilide (0.5 mg/mL)을 첨가하여 20분간 반응시켜 기질로부터 생성되는 p-nitroanilide의 생성량을 405 nm에서 측정하였다. Elastase 저해 활성은 시료용액의 첨가구와 무 첨가군의 흡광도 감소율로 나타내었다.Elastase inhibitory activity was measured as follows. The extract was prepared at a constant concentration, 0.5 mL each was taken in a test tube, 0.5 mL of porcine pancreas elastase (2.5 U / mL) solution dissolved in 50 mM tris-HCl buffer (pH 8.6) was added, followed by 50 mM tris-HCl buffer (pH). Substrate N-succinyl- (L-Ala) 3-p-nitroanilide (0.5 mg / mL) dissolved in 8.6) was added and reacted for 20 minutes, and the amount of p-nitroanilide produced from the substrate was measured at 405 nm. Elastase inhibitory activity was expressed by the absorbance reduction rate of the sample solution added and the group added.
자외선 및 활성산소 등에 의해 유발되어 피부 진피층에 존재하는 matrix -metalloproteinases (MMPs)는 피부노화, 특히 주름생성과 밀접한 관계가 있다. MMPs를 이루는 주요성분으로는 콜라게나제, 젤라티나제 및 엘라스타제 등이 있으며, 자외선과 같은 내·외적 스트레스로 인하여 탄력성, 윤택성이 감소하고 과다 발현된 엘라스타제에 의하여 엘라스틴의 그물망 구조가 깨지게 되면 피부가 처지고 주름이 생기므로 피부의 탄력감소 및 주름생성에 있어서 엘라스타제의 활성 감소는 매우 중요하다. 엘라스틴을 가수분해하는 엘라스타제는 피부 주름과 연관성이 있는 효소로서 대추씨 추출물이 엘라스타제 활성에 미치는 영향을 관찰하였다. Matrix -metalloproteinases (MMPs) induced by UV light and free radicals in the dermal layer of skin are closely related to skin aging, especially wrinkle formation. Main components of MMPs include collagenase, gelatinase, and elastase, and elasticity and moisture are decreased due to internal and external stress such as ultraviolet rays, and the elastin network structure is increased due to overexpressed elastase. When broken, the skin sags and wrinkles, so the reduction of the elastase activity is very important in reducing the elasticity of the skin and wrinkles. Elastase, which hydrolyzes elastin, is an enzyme associated with skin wrinkles and the effect of jujube seed extract on elastase activity was observed.
도 3은 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 엘라스타제 저해 활성을 나타낸 그래프이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이고, 양성 대조군으로 우르솔산(ursolic acid)을 사용하였다. Figure 3 is a graph showing the elastase inhibitory activity according to the concentration of ethanol as the extract solvent of jujube seed extract. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is a jujube seed extract extracted with 95% ethanol, and ursolic acid was used as a positive control.
도 3에서 보듯이, 우르솔산은 농도 의존적으로 엘라스타제 저해능을 보인데 반해 대추씨 추출물은 에탄올 60%가 고농도에서 약간의 저해능을 나타냈었으나, 실험농도 내에 다른 추출물들은 저해능이 거의 보이지 않았다.As shown in Figure 3, ursolic acid showed a concentration-dependent inhibition of elastase, whereas jujube seed extract showed a slight inhibition at 60% ethanol, but other extracts in the experimental concentration showed little inhibition.
(2) 콜라게나제(Collagenase) 저해활성 측정(2) Measurement of collagenase inhibitory activity
콜라게나제 저해활성 측정은 다음과 같이 측정하였다. 즉 반응구는 0.1 M tris-HCl buffer (pH 7.5)에 4 mM CaCl2를 첨가하여, 4-phenylazobenzyl oxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (0.3 mg/mL)를 녹인 기질액 0.25 mL 및 시료용액 0.1 mL의 혼합액에 콜라게나제 (0.2 mg/mL) 0.15 mL를 첨가하여 실온에서 20분간 정치한 후 6% citric acid 0.5 mL을 넣어 반응을 정지 시킨 후, ethyl acetate 1.5 mL을 첨가하여 320 nm에서 흡광도를 측정하였다. 콜라게나제 저해활성은 시료용액의 첨가구와 무 첨가구의 흡광도 감소율로 나타내었다. Collagenase inhibitory activity was measured as follows. In other words, 4 mM CaCl 2 was added to 0.1 M tris-HCl buffer (pH 7.5) and 0.25 mL of substrate solution in which 4-phenylazobenzyl oxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (0.3 mg / mL) was dissolved. 0.15 mL of collagenase (0.2 mg / mL) was added to a 0.1 mL mixture of the sample solution, and the mixture was allowed to stand at room temperature for 20 minutes. Then, 0.5 mL of 6% citric acid was added to stop the reaction. Then, 1.5 mL of ethyl acetate was added thereto. Absorbance was measured at 320 nm. Collagenase inhibitory activity was expressed by the decrease in absorbance of the sample solution added and non-added.
콜라게나제는 결합조직의 탄력을 나타내며 진피층의 90%이상을 구성하고 피부의 주름과 보습 기능을 갖고 있으며, 나이가 들면서 생합성이 감소하는 대표적인 물질이다. 콜라겐을 분해하는 효소는 그 종류가 다양하며 가장 많이 알려져 있는 것이 콜라게나제이다. Collagenase shows the elasticity of connective tissue, constitutes more than 90% of the dermis, has wrinkles and moisturizing function of the skin, and decreases biosynthesis with age. There are many types of enzymes that break down collagen, the most well known is collagenase.
도 4는 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 콜라게나제 저해 활성을 나타낸 그래프이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이고, EGCG는 양성 대조군으로 에피갈로카테킨 갈레이트 (Epigallocatechin gallate)이다. Figure 4 is a graph showing the collagenase inhibitory activity according to the concentration of ethanol, the extract solvent of jujube seed extract. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is the jujube seed extract extracted with 95% ethanol, EGCG is Epigallocatechin gallate as a positive control.
도 4에서 보듯이, 대추씨 추출물의 콜라게나제 저해활성을 측정한 결과 1,000ug/ml의 농도에서 J60이 가장 높은 30.7%의 저해활성을 나타내었다.As shown in Figure 4, the result of measuring the collagenase inhibitory activity of jujube seed extract showed the highest inhibitory activity of 30.7% of J60 at a concentration of 1,000ug / ml.
<시험예 3> 항산화 효과 측정Test Example 3 Antioxidant Effect Measurement
(1) DPPH radical 소거능 측정(1) Measurement of DPPH radical scavenging ability
전자공여능 (EDA; electron donating ability)은 Blois의 방법(1958)에 따라 측정하였다. 각 시료용액 2 mL에 0.2 mM의 1,1-diphenyl-2-picrylhydrazyl (DPPH) 1 mL 넣고 교반한 후 30분간 방치한 다음 517 nm에서 흡광도를 측정하였다. 전자공여 능은 시료용액의 첨가구와 무 첨가군의 흡광도 감소율로 나타내었다. Electron donating ability (EDA) was measured according to Blois's method (1958). 1 mL of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl (DPPH) was added to 2 mL of each sample solution, stirred for 30 minutes, and the absorbance was measured at 517 nm. The electron donating ability was expressed as the absorbance decrease rate of the sample solution added group and the group without addition.
DPPH radical 소거능의 측정은 일종의 전자공여능을 측정하는 방법으로서 환원력이 클수록 강력한 항산화제가 된다는 것에 착안하여 DPPH의 환원 정도를 기준으로 측정물질의 환원력과 항산화력을 가늠할 수 있다. 지질과산화의 연쇄반응에 관여하여 free radical의 전자를 공여하여 산화를 억제시키는 DPPH 전자공여능 실험해서 대추씨 추출물을 10~1,000 ug/ml농도로 조절 및 첨가하여 측정하였다. DPPH radical scavenging ability is a kind of measuring electron donating ability. The higher the reducing power, the more powerful the antioxidant. Based on the reduction of DPPH, it is possible to estimate the reducing power and antioxidant power of the measured substance. DPPH electron donating ability to inhibit oxidation by donating electrons of free radicals in the chain reaction of lipid peroxidation was measured by adjusting and adding the jujube seed extract to a concentration of 10-1,000 ug / ml.
그 결과는 도 5에 나타내었다. 도 5는 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 DPPH 전자공여능 결과를 나타낸 그래프이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이고, BHA는 양성 대조군으로 Butylated hydroxyanisole이다. The results are shown in FIG. 5 is a graph showing the results of DPPH electron donating ability according to the concentration of ethanol as an extract solvent of jujube seed extract. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is a jujube seed extract extracted with 95% ethanol, BHA is a butylated hydroxyanisole as a positive control.
도 5에서 보듯이, 60% 에탄올을 이용한 대추씨 추출물이 다른 추출물과 비교시 높은 DPPH radical 소거능을 나타냄을 확인하였다.As shown in Figure 5, it was confirmed that the jujube seed extract using 60% ethanol shows a high DPPH radical scavenging ability compared with other extracts.
(2) ABTS radical cat ion 소거능 측정 (2) Measurement of ABTS radical cat ion scavenging ability
ABTS radical cation 소거능은 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS)와 potassium persulfate와의 반응으로 ABTS+·radical이 생성되면 특유의 색인 청록색을 띄게 되는데, 시료를 첨가함에 따라 연한녹색으로 decolorization되는 것을 측정하는 방법으로 hydrogen donating antioxidant와 chain breaking antioxidant 모두를 측정할 수 있는 방식이다.ABTS radical cation scavenging ability becomes distinctive index blue green when ABTS + radical is formed by reaction of 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) with potassium persulfate. The addition of hydrogen donating antioxidants and chain breaking antioxidants is a measure of decolorization to light green as added.
ABTS radical을 이용한 항산화력 측정은 ABTS+ cation decolorization assay 방법(Roberta, et al., 1999)에 의하여 측정하였다. 7 mM 2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid)와 2.4 mM potassium persulfate를 혼합하여 실온인 암소에서 24시간 동안 방치하여 ABTS+을 형성시킨 후 ethanol로 희석 하여 ABTS+ 0.1 mL에 시료 0.1 mL를 가하여 1분 동안 방치한 후 732 nm에서 흡광도를 측정하였다.Antioxidant activity using ABTS radical was measured by ABTS + cation decolorization assay method (Roberta, et al., 1999). 7 mM 2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) and 2.4 mM potassium persulfate were mixed for 24 hours in a dark room at room temperature to form ABTS +, diluted with ethanol, and sampled in 0.1 mL ABTS +. 0.1 mL was added and allowed to stand for 1 minute, and then the absorbance was measured at 732 nm.
도 6은 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 ABTS 라디칼 소거능을 나타낸 그래프이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이고, BHA는 양성 대조군으로 Butylated hydroxyanisole이다. Figure 6 is a graph showing the ABTS radical scavenging ability according to the concentration of ethanol, the extraction solvent of jujube seed extract. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is a jujube seed extract extracted with 95% ethanol, BHA is a butylated hydroxyanisole as a positive control.
도 6에서 보듯이, 대추씨 ABTS radical cation 소거능을 측정한 결과 100 ug/ml의 농도에서 44.56 %의 활성을 나타냈으며, 500 ug/ml에서는 99.38 %의 우수한 효과를 나타내었다. 이는 대조군인 BHA와 비교해서도 유사한 결과를 나타내어 상기 DPPH 효과와 같이 천연 항산화제로서의 산업화 적용 가능성이 매우 높은 것으로 판단된다. As shown in Figure 6, jujube seed ABTS radical cation scavenging ability was measured 44.56% activity at a concentration of 100 ug / ml, it was excellent effect of 99.38% at 500 ug / ml. This result is similar to that of the control group BHA, and thus, it is judged that the possibility of industrialization as a natural antioxidant is very high as the DPPH effect.
(3) 과산화수소(Hydrogen peroxide) 소거능 측정(3) Determination of hydrogen peroxide scavenging ability
과산화수소(H2O2) 저해활성은 과산화수소 분석 (Jayaprakasha et al., 2004)에 의해 측정하였다. 농도별 시료용액 1.0 mL와 phosphate-buffer saline (PBS, pH 7.4)에 녹인 40 mM 과산화수소 용액 2.0 mL을 37℃에서 10분간 반응시킨 후 반응액 중에 저해된 과산화수소의 양을 230 nm에서 흡광도를 측정하였다. 합성항산화물질인 BHA와 활성을 비교해보았다.Hydrogen peroxide (H 2 O 2 ) inhibitory activity was determined by hydrogen peroxide analysis (Jayaprakasha et al., 2004). After 1.0 mL of sample solution and 2.0 mL of 40 mM hydrogen peroxide solution dissolved in phosphate-buffer saline (PBS, pH 7.4) were reacted at 37 ° C. for 10 minutes, the absorbance was measured at 230 nm for the amount of hydrogen peroxide inhibited in the reaction solution. . We compared the activity with synthetic antioxidant BHA.
과산화수소 저해활성 측정은 항산화제가 과산화수소와 같은 전구 산화제의 함량을 감소시키는 능력을 측정하는 가장 유용한 방법 중의 하나이다. 과산화수소는 약한 산화제로 효소의 필수기인 티올기를 산화시켜 일부 효소의 활성을 직접적으로 감소시키는 것으로 알려져 있다. 또한 과산화수소는 반응성이 있는 non-radical 물질로 생체막을 직접적으로 통과할 수 있기 때문에 매우 중요하다. 과산화수소는 생체막을 통과하면 다양한 반응을 통해서 반응성이 큰 일중항산소(singlet oxygen) 및 하이드록실 라디칼(hydroxyl radical)로 전환되어 지질과산화 또는 세포내에서 독성을 유발시킨다.Hydrogen peroxide inhibitory activity measurement is one of the most useful methods of measuring the ability of antioxidants to reduce the content of prooxidants such as hydrogen peroxide. Hydrogen peroxide is a weak oxidant and is known to directly reduce the activity of some enzymes by oxidizing the thiol group, an essential group of enzymes. Hydrogen peroxide is also important because it is a reactive, non-radical substance that can pass directly through the biofilm. Hydrogen peroxide is converted into highly reactive singlet oxygen and hydroxyl radicals through various reactions through biofilms to induce lipid peroxidation or toxicity in cells.
도 7은 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 과산화수소 (H2O2) 소거능을 나타낸 그래프이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이고, BHA는 양성 대조군으로 Butylated hydroxyanisole이다. 7 is a graph showing the hydrogen peroxide (H 2 O 2 ) scavenging ability according to the concentration of ethanol as an extract solvent of jujube seed extract. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is a jujube seed extract extracted with 95% ethanol, BHA is a butylated hydroxyanisole as a positive control.
도 7에서 보듯이, 대추씨 추출물의 과산화수소에 대한 저해활성을 측정한 결과 농도 의존적으로 증가하였으며, 그 중 60% 에탄올 추출물이 양성 대조군과 유사한 활성을 나타내었다. As shown in FIG. 7, the inhibitory activity of the jujube seed extract was increased depending on the concentration of hydrogen peroxide. Among them, 60% ethanol extract showed similar activity as the positive control.
(4) 수퍼옥사이드 음이온 라디칼(Superoxide anion radical) 소거능 측정(4) Superoxide anion radical scavenging ability measurement
수퍼옥사이드 음이온 라디칼 소거능은 Fridovich의 방법에 따라 NBT 환원방법으로 측정하였다. 각 시료용액 0.1 ml와 0.1 M potassium phosphate buffer (pH 7.5) 0.4 ml에 xanthine (0.4 mM)과 NBT (0.24 mM)을 녹인 기질액 1 ml을 첨가하고 xanthine oxidase (0.2 U/ml) 1 ml를 가하여 37℃에서 20분간 반응시킨 후 1 N HCl 1 ml을 가하여 반응을 종료시킨 다음, 반응액 중에 생성된 수퍼옥사이드 음이온 라디칼의 양을 560 nm 에서 흡광도를 측정하였다.Superoxide anion radical scavenging ability was measured by NBT reduction method according to Fridovich's method. To 1 ml of each sample solution and 0.4 ml of 0.1 M potassium phosphate buffer (pH 7.5), add 1 ml of xanthine (0.4 mM) and NBT (0.24 mM), and add 1 ml of xanthine oxidase (0.2 U / ml). After reacting at 37 ° C. for 20 minutes, 1 ml of 1 N HCl was added to terminate the reaction. Then, the amount of superoxide anion radical generated in the reaction solution was measured at 560 nm.
수퍼옥사이드 음이온 라디칼은 다른 유해 활성산소의 전구체로 작용하므로 이 물질에 대한 소거활성 측정은 시료의 항산화 활성 탐색에 효과적인 방법으로 알려져 있다. Since superoxide anion radicals act as precursors of other harmful free radicals, the scavenging activity of these substances is known to be an effective method for screening the antioxidant activity of samples.
도 8은 대추씨 추출물의 추출용매인 에탄올의 농도에 따른 수퍼옥사이드 음이온 라디칼 소거능을 나타낸 그래프이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이고, BHA는 양성 대조군으로 Butylated hydroxyanisole이다. 8 is a graph showing the superoxide anion radical scavenging ability according to the concentration of ethanol which is an extract solvent of jujube seed extract. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is a jujube seed extract extracted with 95% ethanol, BHA is a butylated hydroxyanisole as a positive control.
도 8에서 보듯이, 대추씨 추출물은 모든 농도에서 20% 정도의 수퍼옥사이드 음이온 라디칼 소거활성이 나타내었다.As shown in Figure 8, the jujube seed extract showed about 20% superoxide anion radical scavenging activity at all concentrations.
<시험예 4> 항균력 측정Test Example 4 Antibacterial Activity
(1) 대상균주(1) Target strain
Candida albicans(KCTC 7965)의 배양을 위한 액체배지로는 YM broth (YMB)를 사용 하였으며, Escherichia coli(KCTC 1039) 및 Staphylococcus epidermidis(KCTC 1917)의 액체배지로는 nutrient broth (NB)를 사용하였고, Staphylococcus aureus(KCTC 1621)의 액체배지로는 tryptic soy broth (TSB)를 사용하였고 Propionibacterium acnes(KCTC 3314)는 GAM을 사용하였고 고체배지는 상기 액체배지에 agar를 첨가하여 사용하였다. 균주는 BOD incubator에서 생육 온도조건별로 배양하였다. Candida in a liquid medium for the culture of the albicans (KCTC 7965) it was used as the YM broth (YMB), Escherichia Nutrient broth (NB) was used for the liquid medium of coli (KCTC 1039) and Staphylococcus epidermidis (KCTC 1917), tryptic soy broth (TSB) was used for the liquid medium of Staphylococcus aureus (KCTC 1621), and Propionibacterium acnes (KCTC) was used. 3314) used GAM and solid medium was used by adding agar to the liquid medium. Strains were cultured by growth temperature in a BOD incubator.
(2) 감수성검사를 위한 디스크 확산법(2) Disk Diffusion Method for Susceptibility Testing
항균력 측정은 paper disc법을 이용하여 측정하였다. 즉, 평판배지에 배양된 각 균주를 1 백금이랑 취해서 액체배지 10 mL에서 18~24시간 배양하여 0.85% 식염수에 풀어 잘 섞은 후 0.5 McFarland 탁도 (spectrophotometer, 530nm)로 맞추어 균 농도가 약 1~5X106 CFU/mL가 되도록 하였다. 균액을 소독된 면봉을 이용하여 MH-GMB 배지에 고르게 도말하고 대추씨 추출물을 각각 농도 의존적으로 제작한 디스크와 항생제(대조군) 디스크를 올렸다. 37℃에서 18~24시간 배양하여 disc주위의 clear zone (mm)의 직경을 측정하였다. 그 결과는 도 5 및 도 6에 나타내었다.Antibacterial activity was measured using a paper disc method. In other words, each strain cultured on a plate medium with 1 platinum, incubated for 18-24 hours in 10 mL of liquid medium, dissolved in 0.85% saline and mixed well, and then adjusted to 0.5 McFarland turbidity (spectrophotometer, 530 nm), and the concentration of the strain was about 1-5X10. 6 CFU / mL. The sterilized swabs were evenly spread on MH-GMB medium, and the disc and antibiotic (control) discs prepared with jujube seed extract in concentration-dependent manner were loaded. The diameter of the clear zone (mm) around the disc was measured by incubating at 37 ° C for 18-24 hours. The results are shown in FIGS. 5 and 6.
도 9 및 도 10은 대추씨 추출물의 미생물에 대한 항균 활성을 나타낸 사진이다. 여기에서, J20는 20% 에탄올로 추출한 대추씨 추출물이고, J40는 40% 에탄올로 추출한 대추씨 추출물이고, J60는 60% 에탄올로 추출한 대추씨 추출물이고, J80는 80% 에탄올로 추출한 대추씨 추출물이고, J95는 95% 에탄올로 추출한 대추씨 추출물이다. 그 결과, 대추씨 추출물은 그람양성, 음성, 진균에 대해서 항균력이 없음을 확인하였다. 9 and 10 are photographs showing the antimicrobial activity of the jujube seed extract against microorganisms. Here, J20 is jujube seed extract extracted with 20% ethanol, J40 is jujube seed extract extracted with 40% ethanol, J60 is jujube seed extract extracted with 60% ethanol, J80 is jujube seed extract extracted with 80% ethanol , J95 is a jujube seed extract extracted with 95% ethanol. As a result, the jujube seed extract was confirmed that there is no antimicrobial activity against gram positive, negative, fungi.
<시험예 5> 세포재생 측정Test Example 5 Regeneration of Cells
(1) 세포배양(1) Cell culture
CCRF S-180 Ⅱ (Mouse skin fibroblast cell line, KCLB No. 10008)을 한국세포주은행(Korean Cell Line Bank (Seoul, Korea))으로부터 분양받았다. 세포배양액은 Dulbecco's modified Eagle's medium (DMEM)을 사용하였다. 10 % fetal bovine serum (FBS), 100 U/ml penicillin (100 U/ml), and 100 mg/ml streptomycin (100 mg/ml)을 첨가하였다. 계대배양은 0.05% trypsin, 0.53 mM EDTA를 사용하였다. CCRF S-180 II (Mouse skin fibroblast cell line, KCLB No. 10008) was distributed from Korean Cell Line Bank (Seoul, Korea). Cell culture medium was used Dulbecco's modified Eagle's medium (DMEM). 10% fetal bovine serum (FBS), 100 U / ml penicillin (100 U / ml), and 100 mg / ml streptomycin (100 mg / ml) were added. Subculture was used 0.05% trypsin, 0.53 mM EDTA.
(2) MTT assay에 의한 세포 생존율 평가(2) Cell viability evaluation by MTT assay
대추씨의 세포에 대한 독성은 MTT assay 방법으로 분석하였다. 이는 mitochondrial dehydrogenases에 의하여 formazan으로 전환되는 것을 측정하는 방법으로 96 well plate에 1X 104cell/well의 CCRF S-180 Ⅱ (Mouse skin fibroblast cell)을 분주하고 대추씨 60%에탄올 추출물을 농도별 (62.5 ~ 1000 ug/ml)로 처리하여 24시간 동안 배양하였다. Well 당 20 ul의 MTT solution을 첨가하여, 37℃ 5% CO2 조건하에서 4시간 동안 반응시킨 후 microplate reader를 이용하여 490 nm에서 흡광도 변화를 측정하여 대조군에 대한 세포 생존율을 백분율로 표시하였다. Toxicity of jujube cells was analyzed by MTT assay method. This method measures the conversion of mitochondrial dehydrogenases into formazan by dispensing CCRF S-180 Ⅱ (Mouse skin fibroblast cells) of 1X 10 4 cells / well in 96 well plates and extracting 60% ethanol extract of jujube seeds by concentration (62.5). ~ 1000 ug / ml) was incubated for 24 hours. 20 ul of MTT solution per well was added and reacted for 4 hours at 37 ° C. 5% CO 2 , and then the absorbance change was measured at 490 nm using a microplate reader to express cell viability as a percentage.
In vitro 실험을 토대로 가장 저해 효능이 좋았던 J60 이용하여 50~200 ug/ml의 농도에서의 CCRF S-180 Ⅱ(Mouse fibroblast cell)에 대한 세포 생존율을 측정하였다. Based on in vitro experiments, the cell survival rate of CCRF S-180 II (Mouse fibroblast cells) was measured at a concentration of 50-200 ug / ml using J60, the most inhibitory effect.
도 11은 대추씨 추출물의 세포 생존율을 나타낸 것이다. 여기에서 보듯이, 200ug/ml의 농도에서 97.9%의 세포 생존율을 보였다. Figure 11 shows the cell viability of jujube seed extract. As shown here, the cell viability was 97.9% at the concentration of 200 ug / ml.
(3) UVB에 대한 J60의 세포사멸 억제효과 측정(3) Measurement of the inhibitory effect of J60 on apoptosis on UVB
자외선은 피부 세포에 조사되면 직, 간접적으로 손상을 주게 되는데 직접적으로 DNA구조 변화를 유도하거나 산화 반응을 통해 세포 구성 물질에 손상을 주게 된다.When UV rays are irradiated to the skin cells, the UV rays directly or indirectly damage the cell structure by directly inducing DNA structure changes or oxidative reactions.
UVB를 세포에 조사하여 세포를 사멸시키고 시료를 이용하여 세포의 사멸이 얼마나 억제되는지에 대한 정도를 확인하기 위해 UVB를 조사하고 MTT 시약을 처치하여 세포사멸정도를 확인하였다. UVB was irradiated to the cells to kill the cells, and using the sample to determine the extent of inhibition of cell death, UVB was examined and treated with MTT reagent to confirm the degree of cell death.
HaCaT cell (Human Keratynocyte Cell)을 96 well plate에 Seeding하여 24시간 배양 후 serum free로 배지를 교환하고 24시간 후 96 well plate에서 배양중인 각질형성세포에 UVB (250mJ/cm2)를 조사하여 광 손상을 주고 J60 (60% ethanol extracts of Jujube seed)을 다양한 농도로 처치한 후 24시간 배양하고 MTT (Thiazolyl Blue Tetra-zolium Bromide) 시약을 처치하고 4시간 후 plate의 상층액을 제거하고 Ethanol : DMSO = 1 : 1 solution을 각 well에 처치하고 540nm에서 흡광도를 관찰하였다.Seeding HaCaT cells (Human Keratynocyte Cells) in 96 well plates for 24 hours, incubating with serum free medium, and irradiating UVB (250mJ / cm 2 ) to keratinocytes incubated in 96 well plates for 24 hours After treatment with J60 (60% ethanol extracts of Jujube seed) at various concentrations, incubate for 24 hours, treatment with Thiozolyl Blue Tetra-zolium Bromide (MTT) reagent, remove supernatant from plate after 4 hours, and remove Ethanol: DMSO = A 1: 1 solution was treated in each well and the absorbance was observed at 540 nm.
도 12는 HaCaT 세포에서 UVB로 인한 세포사멸에 대한 대추씨 추출물의 보호 효과를 나타낸 그래프이다. 여기에서 보듯이, 대추씨 추출물을 자외선을 조사한 후 첨가되면 세포의 생존을 증가시켜 주는 결과를 보여주며, 이는 대추씨 추출물이 노화 현상을 억제하는데 효과가 있음을 보여준다고 할 수 있다. 12 is a graph showing the protective effect of jujube seed extract against UVB-induced apoptosis in HaCaT cells. As shown here, the addition of the jujube seed extract after irradiation with ultraviolet rays shows the result of increasing the survival of the cells, which can be said that the jujube seed extract is effective in suppressing the aging phenomenon.
(4) Gelatin Zymography(4) Gelatin Zymography
Gelatin을 분해하는 물질인 MMP-2, MMP-9의 특성을 이용해 대추씨 추출물의 MMP-2, MMP-9 활성에 미치는 영향을 알아보기 위해 Gelatin zymography를 실시하였다. 대추씨의 MMP-2와 MMP-9의 발현정도에 미치는 영향을 알아보기 위해 Gelatin Zymography 방법을 이용하였다. 10% SDS-polyacrylamide gel(30% acrylamide/ 0.8% bis-acrylamide, 1.5M Tris-HCl(pH8.8), 10% SDS, 10% APS, TEMED, 0.2% Gelatin, DW)에 정량한 배지와 sample buffer를 1:1로 섞은 후 전기영동 하였다. SDS를 제거하기 위해 renaturing buffer (Triton X-1002% in D.W)에 30분 동안 shaking 후 Developing buffer (50mM Tris-HCl, 0.2M NaCl, 5mM CaCl2, 1% TritonX-100)에 넣은 후 37℃에서 12시간 반응시켰다. Staining Solution인 0.5% coomassie blue에서 1시간동안 염색하고, Destaining Solution (Methanol : Acetic acid : D.W = 5 : 1 : 4)에 1시간 동안 탈색한 다음 투명한 밴드를 확인하였다. Gelatin zymography was performed to investigate the effect of jujube seed extract on MMP-2 and MMP-9 activity using the properties of MMP-2 and MMP-9, which degrades gelatin. Gelatin Zymography was used to investigate the effect of jujube seed on the expression level of MMP-2 and MMP-9. Medium and sample quantified on 10% SDS-polyacrylamide gel (30% acrylamide / 0.8% bis-acrylamide, 1.5M Tris-HCl (pH8.8), 10% SDS, 10% APS, TEMED, 0.2% Gelatin, DW) The buffer was mixed 1: 1 and electrophoresed. To remove SDS, shake for 30 minutes in renaturing buffer (Triton X-1002% in DW), add to Developing buffer (50mM Tris-HCl, 0.2M NaCl, 5mM CaCl 2 , 1% TritonX-100), and then at 37 ° C. The reaction was carried out for 12 hours. After staining for 1 hour in 0.5% coomassie blue, a staining solution, destaining solution (Methanol: Acetic acid: DW = 5: 1: 4) for 1 hour and then confirmed a transparent band.
도 13은 대추씨 추출물의 MMP-2 및 MMP-9 발현에 미치는 영향을 나타낸 그래프이다. 여기에서 보듯이, UVB (50mJ/cm2)를 처치한 구간에서 MMP-2와 MMP-9의 발현량이 증가함을 확인할 수 있다. 이에 대추씨 EtOH 60% 추출물을 농도별로 처리하였을 때, 50ug/ml을 처치하였을 때는 별다른 발현량의 변화가 나타나지 않았으나 100ug/ml, 200ug/ml을 처치한 구간에서 농도 의존적으로 MMP-2와 MMP-9의 발현량이 줄어드는 것을 확인할 수 있었다.Figure 13 is a graph showing the effect on the expression of MMP-2 and MMP-9 of jujube seed extract. As shown here, it can be seen that the expression level of MMP-2 and MMP-9 increased in the section treated with UVB (50mJ / cm 2 ). Thus, when treated with 60% extract of jujube seed EtOH by concentration, 50 ug / ml treatment did not show a change in expression, but the concentration-dependent MMP-2 and MMP- in the section treated with 100 ug / ml, 200 ug / ml It was confirmed that the expression level of 9 decreases.
(5) Western blot(5) Western blot
UVB가 사람 각질세포에 미치는 영향을 알아보기 위해 HaCaT cell에 UVB(50mJ/cm2)를 조사하여 콜라겐의 전구물질인 Pro-Collagen Type 1과 MMPs의 발현과 관련 있는 kinase들의 활성화에 미치는 영향을 알아보기 위하여 Western blot 방법을 이용하여 단백질 발현량을 측정하였다. To investigate the effect of UVB on human keratinocytes, we investigated the effects of UVB (50mJ / cm 2 ) on HaCaT cells on the activation of kinase related to the expression of collagen precursors Pro-Collagen Type 1 and MMPs. In order to see the protein expression was measured using Western blot method.
UVB 50mJ/cm2를 조사 후 대추씨 추출물을 농도별로 처리하고 세포를 수거하여 PBS로 세척 후 RIPA buffer (M.biotek)로 1시간동안 용해시킨 후 12,000rpm, 4℃에서 10분간 원심분리하여 상등액을 회수하였다. 회수된 상등액은 SDS sample buffer (M.biotek)을 첨가하여 90℃에서 10분간 변성(denaturation)시킨 후 단백질을 SDS-PAGE로 분자량별로 분리하였다. 분리된 단백질은 100V의 조건에서 1시간동안 nitrocellulose membrane (Whatman, UK)으로 전이시키고 0.1% BSA 용액으로 blocking 시킨 후 membrane을 Antibody 용액에 담가 4℃에서 18시간 반응시켰다. TBST (10mM Tris-HCl (pH 7.5), 150mM NaCl, 0.2% Tween 20)로 10분씩 3회 세척하였다. 세척된 membrane을 화학적 형광을 낼 수 있는 horse radish peroxidase (HRP)와 결합시키기 위해 2시간 동안 반응시킨 후 화학 발광 이미지 장치(ATTO사)를 이용하였다.After irradiating UVB 50mJ / cm 2 , the jujube seed extract was treated by concentration, cells were collected, washed with PBS, dissolved in RIPA buffer (M.biotek) for 1 hour, and then centrifuged at 12,000rpm and 4 ° C for 10 minutes. Was recovered. The recovered supernatant was denatured at 90 ° C. for 10 minutes by adding SDS sample buffer (M.biotek), and proteins were separated by molecular weight by SDS-PAGE. The isolated protein was transferred to nitrocellulose membrane (Whatman, UK) for 1 hour at 100V, blocked with 0.1% BSA solution, and the membrane was immersed in Antibody solution for 18 hours at 4 ℃. Washed three times for 10 min with TBST (10 mM Tris-HCl, pH 7.5), 150 mM NaCl, 0.2% Tween 20). The washed membrane was reacted for 2 hours to combine with the chemically fluorescent horse radish peroxidase (HRP), and then used a chemiluminescence imaging device (ATTO).
도 14는 대추씨 추출물이 UVB 조사된 Pro-Collagen Type 1과 MMP-2 및 MMP-9 발현에 미치는 영향을 나타낸 그래프이다. 여기에서 보듯이, Pro-Collagen Type 1의 발현량 확인결과 UVB 조사시 줄어드는 것을 확인할 수 있었고 양성 대조군과 J60은 농도 의존적으로 증가함을 관찰할 수 있었다. MMP-2와 MMP-9의 경우 MMP-9는 가시적인 발현량의 억제가 확인되었다.14 is a graph showing the effect of jujube seed extract on UV-irradiated Pro-Collagen Type 1 and MMP-2 and MMP-9 expression. As shown here, as a result of confirming the expression level of Pro-Collagen Type 1, it was confirmed that the UVB irradiation decreased, and the positive control group and J60 increased in a concentration dependent manner. In the case of MMP-2 and MMP-9, it was confirmed that MMP-9 suppressed the visible expression level.
<제형예 1> 대추씨 추출물 함량에 따른 선크림 제형 개발 Formulation Example 1 Development of Sunscreen Formulation According to Jujube Seed Extract Content
하기 표 1에 나타낸 바와 같이 대추씨 추출물(이하 "HC-Phytoju"라 명명함)의 함량에 따른 선크림 제형을 제조하였다.A sunscreen formulation was prepared according to the content of jujube seed extract (hereinafter referred to as "HC-Phytoju") as shown in Table 1 below.
PhasePhase Trade NameTrade Name HC-AHC-A HC-BHC-B HC-CHC-C
A phaseA phase D.I-waterD.I-water up to 100up to 100 up to 100up to 100 up to 100up to 100
Disodium EDTADisodium EDTA Q.SQ.S Q.SQ.S Q.SQ.S
1.2-Hexandiol1.2-Hexandiol Q.SQ.S Q.SQ.S Q.SQ.S
MgSO4MgSO4 Q.SQ.S Q.SQ.S Q.SQ.S
1,3-BG1,3-BG Q.SQ.S Q.SQ.S Q.SQ.S
D.P.GD.P.G Q.SQ.S Q.SQ.S Q.SQ.S
HC-PhytojuHC-Phytoju 1.001.00 3.003.00 5.005.00
B phaseB phase Parsol MCXParsol mcx Q.SQ.S Q.SQ.S Q.SQ.S
Parsol EHSParsol ehs Q.SQ.S Q.SQ.S Q.SQ.S
Neoheliopan E1000Neoheliopan E1000 Q.SQ.S Q.SQ.S Q.SQ.S
HallBrite BHBHallBrite BHB Q.SQ.S Q.SQ.S Q.SQ.S
Finoslov TNFinoslov TN Q.SQ.S Q.SQ.S Q.SQ.S
Vit.E AcetateVit.E Acetate Q.SQ.S Q.SQ.S Q.SQ.S
C phaseC phase KF 995KF 995 Q.SQ.S Q.SQ.S Q.SQ.S
Bentone 38VBentone 38V Q.SQ.S Q.SQ.S Q.SQ.S
D phaseD phase KF 995KF 995 Q.SQ.S Q.S Q.S Q.SQ.S
DC 200/6csDC 200 / 6cs Q.SQ.S Q.SQ.S Q.S Q.S
Abil EM 90Abil EM 90 Q.SQ.S Q.SQ.S Q.SQ.S
E phaseE phase Silica 67 SDMSilica 67 SDM Q.SQ.S Q.SQ.S Q.SQ.S
Micro TiO2 035 ASMicro TiO2 035 AS Q.SQ.S Q.SQ.S Q.SQ.S
Z Cote HP-1Z Cote HP-1 Q.SQ.S Q.SQ.S Q.SQ.S
F phaseF phase Frag-80890Frag-80890 Q.SQ.S Q.SQ.S Q.SQ.S
Q.S. (Quantum sufficient : Proper quantity)Q.S. (Quantum sufficient: Proper quantity)
<시험예 6> 안정성 평가 방법<Test Example 6> Stability Evaluation Method
(1) pH 측정(1) pH measurement
pH 측정은 Ohaus(Starter 3100F)사의 pH meter를 이용하여 측정하였다. 측정하기 전에 유리전극은 미리 염기성 완충액이나 증류수에 수 시간 담궈 두고 pH meter는 전원에 연결하고 10분 이상 두었다가 사용하였다. 검출부는 물로 잘 씻어 가볍게 닦아 낸 다음 사용하였다.pH measurement was performed using a pH meter of Ohaus (Starter 3100F). Before the measurement, the glass electrode was immersed in basic buffer or distilled water for several hours, and the pH meter was connected to a power source and left for 10 minutes or more. The detector was washed well with water and wiped lightly before use.
도 15는 대추씨 추출물 함량에 따른 선크림 제형의 pH 변화를 측정하여 나타낸 그래프이다. 여기에서 보듯이, 0, 1, 3, 5, 7, 14, 28, 60, 90일차로 12주간 25℃에서 보관한 선크림의 pH를 측정한 결과, 처방 HC-A, HC-B 및 HC-C 제형에서 보관기간 동안 대추씨 추출물의 함량에 따라 pH 수치상에서 약간의 차이가 관찰되었다. Figure 15 is a graph showing the measurement of the pH change of the sunscreen formulation according to the jujube seed extract content. As shown here, the pH of the sunscreen stored at 25 ° C. for 12 weeks on days 0, 1, 3, 5, 7, 14, 28, 60 and 90 was measured, and the prescription HC-A, HC-B and HC- In the C formulation, slight differences in pH values were observed depending on the content of the jujube seed extract during the storage period.
(2) 경시적 점도 변화 측정(2) Measurement of viscosity change over time
점도 측정은 Brookfield Viscometer(Brookfield LV-Ⅱ+, Brookfield Engineering Laboratories Inc., Middleboro, MA, USA)를 이용하여 측정하였다. 기포의 영향을 줄이기 위해 제조 시 탈포하여 점도 값에 영향을 줄 수 있는 요인을 최소화하여 측정하였다. 25℃에서 보관한 선크림을 스핀들(spindle) No.4를 택하여 12rpm에서 1분간 점도를 측정하였다. 0, 1, 3, 5, 7, 15, 30, 60, 90일차로 점도를 12주간 측정하였다.Viscosity measurements were measured using a Brookfield Viscometer (Brookfield LV-II +, Brookfield Engineering Laboratories Inc., Middleboro, MA, USA). In order to reduce the effect of the bubble was measured by minimizing the factors that can affect the viscosity value by defoaming during manufacture. The viscosity of the sunscreen stored at 25 ° C. was selected at spindle No. 4 for 1 minute at 12 rpm. The viscosity was measured for 12 weeks on the 0, 1, 3, 5, 7, 15, 30, 60, and 90 days.
도 16은 대추씨 추출물 함량에 따른 선크림 제형의 점도 변화를 측정하여 나타낸 그래프이다. 여기에서 보듯이, 0, 1, 3, 5, 7, 14, 28, 60, 90일차로 12주간 25℃에 보관한 선크림의 점도를 측정한 결과, 처방 HC-A, HC-B 및 HC-C 모든 제형에서 3개월 동안 26,000-17,500cp로 점도의 차이가 나타났고, 특히 HC-B 및 HC-C 제형의 경우 보관기간 동안에 따라 점도의 하락이 관찰됨을 확인할 수 있었다.Figure 16 is a graph showing the viscosity change of the sunscreen formulation according to the jujube seed extract content. As shown here, the viscosity of the sunscreen stored at 25 ° C. for 12 weeks on days 0, 1, 3, 5, 7, 14, 28, 60, and 90 was measured. As a result, prescription HC-A, HC-B and HC- C All formulations showed a difference in viscosity to 26,000-17,500 cps for 3 months, and especially in the case of HC-B and HC-C formulations, a decrease in viscosity was observed during the storage period.
(3) 각 온도조건별(0℃, 25℃ 및 45℃) 경시적 안정도 관찰(3) Observation of stability over time for each temperature condition (0 ℃, 25 ℃ and 45 ℃)
선크림을 투명 용기에 담아 0℃, 25℃ 및 45℃에서 각각 12주간 보관하면서 0, 1, 3, 5, 7, 15, 30, 60, 90일차까지 온도별 안정성을 평가한다. 선크림의 자발적인 경시적 열화 현상에 따른 화학적 및 물리적 변화를 알아보기 위해서 온도 안정성 평가를 하였다. 고온(45℃)에서는 외관의 산패, 변색, 변취, 부유, 침전, 분리 등을 중점하여 관찰하였고, 저온에서는 응고, 침전, 분리 등의 화학적 물리적 변화를 관찰하였다.The sunscreen is placed in a transparent container and stored at 0 ° C., 25 ° C. and 45 ° C. for 12 weeks, respectively, and evaluated for stability at temperatures up to 0, 1, 3, 5, 7, 15, 30, 60, and 90 days. Temperature stability was evaluated to investigate chemical and physical changes caused by spontaneous deterioration of sunscreen over time. At high temperature (45 ℃), the effect was observed on rancidity, discoloration, discoloration, flotation, sedimentation, separation, etc., and at the low temperature, physical and chemical changes such as coagulation, precipitation, and separation were observed.
각 처방별로 제조된 선크림을 투명 용기에 담아 0℃, 25℃ 및 45℃에서 각각 12주간 보관하면서 1, 3, 5, 7, 14, 28, 60 및 90일차까지 온도별 안정성을 평가하여 하기 표 2(0℃), 표 3(25℃) 및 표 4(45℃)에 각각 온도조건별 경시적 안정도 결과를 나타내었다.  The sunscreen prepared for each prescription was placed in a transparent container and stored for 12 weeks at 0 ° C, 25 ° C and 45 ° C, respectively, and evaluated for stability by temperature until the 1st, 3, 5, 7, 14, 28, 60 and 90 days. 2 (0 ° C), Table 3 (25 ° C) and Table 4 (45 ° C) show the stability results over time, respectively.
SampleDay SampleDay HC-AHC-A HC-BHC-B HC-CHC-C
1One OO OO OO
33 OO OO OO
55 OO OO OO
77 OO OO OO
1414 OO OO OO
2828 OO OO OO
6060 OO OO OO
9090 OO OO OO
O : Stable X : UnstableO: Stable X: Unstable
SampleDay SampleDay HC-AHC-A HC-BHC-B HC-CHC-C
1One OO OO OO
33 OO OO OO
55 OO OO OO
77 OO OO OO
1414 OO OO XX
2828 OO XX XX
6060 OO XX XX
9090 OO XX XX
O : Stable X : UnstableO: Stable X: Unstable
SampleDay SampleDay HC-AHC-A HC-BHC-B HC-CHC-C
1One OO OO OO
33 OO OO OO
55 OO OO OO
77 OO OO XX
1414 OO XX XX
2828 OO XX XX
6060 OO XX XX
9090 OO XX XX
O : Stable X : UnstableO: Stable X: Unstable
상기 표 2에서 보듯이, 0℃에 보관한 선크림(HC-A, HC-B, HC-C)의 경우 28일동안 크리밍이나 응집의 현상 없이 안정한 것으로 관찰되었으나, 표 3에서 25℃에 보관한 선크림의 경우 B는 28일차, C는 14일차 크리밍과 응집 현상이 일어나 안정성이 불안한 것으로 관찰되었으며, 표 4에서 보듯이 45℃에 보관한 선크림의 경우 B는 14일차, C는 7일차 이후에 크리밍과 응집 현상이 일어나 안정성이 불안한 것으로 관찰되었다.As shown in Table 2, the sunscreen (HC-A, HC-B, HC-C) stored at 0 ℃ was observed to be stable for 28 days without the phenomenon of creaming or aggregation, but stored at 25 ℃ in Table 3 In the case of sunscreen, B was 28 days, C was 14 days, and it was observed to be unstable due to the creaming and agglomeration. As shown in Table 4, B was 14 days and C was 7 days after the sunscreen stored at 45 ℃. Creaming and flocculation occurred, resulting in instability.
(4) 온도순환 (Cycle chamber)에 따른 안정성 시험(4) Stability test according to temperature cycle (Cycle chamber)
선크림을 투명 용기에 담아 -5℃, 25℃, 50℃에서 각각 8시간 보관한 후 이를 1 dah/1 cycle로 하여 14회 반복 시행하여 0, 1, 3, 5, 7, 14일차로 2주간 동안온도 순환에 따른 안정성을 평가하였다. 온도순환(Cycle chamber)에 따른 안정성 시험법은 4계절이 분명한 우리나라에서 화장품의 저온 및 고온의 보관조건에 따른 물성변화를 관찰하기 위하여 실시하고 있으며, 또한 온도 변화에 따라 유화·가용화에서의 물성변화를 관찰하기 위하여 실시한다. 제품의 대부분은 고온에서 가수분해 현상 및 기타 현상 등이 빨리 일어나며, 저온인 경우는 부피팽창, 용해도차에 의한 계면막 손상, 침전 등이 일어난다. 온도순환(Cycle chamber)에 따른 안정성 시험법은 이런 현상을 짧은 기간 내에 체크할 수 있다. 그 결과를 하기 표 5에 나타내었다.Put the sunscreen in a transparent container and store it for 8 hours at -5 ℃, 25 ℃, 50 ℃, and repeat it 14 times with 1 dah / 1 cycle for 2 weeks on 0, 1, 3, 5, 7, 14 days. The stability with temperature cycling during the process was evaluated. The stability test method according to the temperature cycle (Cycle chamber) is carried out to observe the change of physical properties according to the storage conditions of low and high temperature of cosmetics in Korea with four distinct seasons, and also the change of physical properties in emulsification and solubilization according to temperature change. To observe. Most of the products are hydrolysis and other phenomena occur quickly at high temperatures, and at low temperatures, volume expansion, interfacial membrane damage due to solubility difference, and precipitation occur. The stability test by the cycle chamber can check this phenomenon in a short period of time. The results are shown in Table 5 below.
SampleDay SampleDay HC-AHC-A HC-BHC-B HC-CHC-C
1One OO OO OO
33 OO OO XX
55 OO XX XX
77 OO XX XX
1414 OO XX XX
O : Stable X : UnstableO: Stable X: Unstable
상기 표 5에서 보듯이, 선크림 HC-B, HC-C에서 크리밍, 응집, 분리등의 물성 변화가 나타났으며, HC-A는 14 cycle모두에서 상의 분리와 변색,변취 없이 안정함을 육안으로 확인할 수 있었다.As shown in Table 5, physical properties such as creaming, agglomeration, and separation were shown in sunscreen HC-B and HC-C, and HC-A was stable without phase separation, discoloration, and discoloration in all 14 cycles. It could be confirmed as.
<시험예 7> 유효성 평가(SPF, PA)Test Example 7 Evaluation of Effectiveness (SPF, PA)
본 시험은 화장품법 제9조에 규정된 '피부를 곱게 태워주거나 자외선으로부터 피부를 보호하는데 도움을 주는 기능성화장품'에 대한 「기능성화장품 심사에 관한 규정」(식품의약품안전처고시 제2015-14호)의 '자외선차단효과 측정방법 및 기준' 에 따라 수행되었다.This test is based on the `` Regulations on the Functional Cosmetics Examination '' (Food and Drug Safety Notice No. 2015-14) on the `` Functional Cosmetics that Help to Burn Skin Finely or Protect Skin from UV Light '' as defined in Article 9 of the Cosmetic Act. It was carried out according to 'Method and Criteria for Measuring UV Protection Effect'.
(1) 시험부위(1) Test site
시험은 피험자 등에 실시하였다. 시험부위는 피부손상, 과도한 털 또는 색조에 특별히 차이가 있는 부분을 피하여 선택하였고, 깨끗하고 마른 상태였다.The test was conducted on the subject and the like. The test site was selected to avoid skin damage, excessive hairs or areas of particular color tone and was clean and dry.
(2) 시험물질 적용 방법(2) Test substance application method
척추부위를 제외한 피험자의 등에 표준 시료 및 시험시료 도포면적을 35㎠로 하여 2.0 ㎎/㎠의 양(총 70.0 ㎎)으로 시험부위에 도포하였다. 정확한 양으로 시료를 도포하기 위하여 마이크로 피펫을 사용하였다. 시료는 피부 표면에 여러 번 균일하게 점적 한 후 손가락 골무 혹은 스패츌러를 이용하여 균일하게 도포하였다.A standard sample and test sample application area on the subject's back, except for the spinal region, were applied to the test site in an amount of 2.0 mg / cm 2 (70.0 mg total). Micro pipettes were used to apply the sample in the correct amount. Samples were evenly applied to the surface of the skin several times and then uniformly applied using a finger thimble or spatula.
자외선 조사부위의 구획Section of ultraviolet irradiation site
제품 도포면적을 35㎠로 하여 0.8㎝X 0.8㎝ 크기의 면적을 갖는 6개의 정사각형 조사부위를 구획하였다.Six square irradiation sites having an area of 0.8 cm × 0.8 cm were partitioned with a product application area of 35 cm 2.
(3) 사용장비(3) Equipment used
(가) 자외선 인공 조사기 (Multiport solar simulator 601, V2.5 Solar Light, USA)(A) UV artificial irradiator (Multiport solar simulator 601, V2.5 Solar Light, USA)
이 장비는 태양광과 유사한 연속적인 방사 스펙트럼을 갖고, 특정 피크를 나타내지 않는 300watt 제논아크램프 (Xenon arc lamp)를 광원으로 탑재하였으며, 램프로부터 조사된 자외선은 색선별 거울 (dichroic mirror)과 조준 렌즈(collimating lens)를 거친 후 6개의 액체 광도체 (liquid light guide)를 통해 0.8㎝ X 0.8㎝ 크기의 정사각형으로 방출된다. 특수 필터를 사용하여 인체에 특히 유해한 290nm 이하의 자외선 영역의 파장을 제거한다.The instrument is equipped with a 300watt Xenon arc lamp, which has a continuous emission spectrum similar to sunlight and does not exhibit a specific peak, as the light source is irradiated with a dichroic mirror and aiming lens. After passing through a collimating lens, the liquid is emitted in a square size of 0.8 cm X 0.8 cm through six liquid light guides. Special filters are used to remove wavelengths in the ultraviolet region below 290 nm, which are particularly harmful to humans.
(나) 광량측정기 (PMA-2100, Solar Light, USA) (B) Photometer (PMA-2100, Solar Light, USA)
㎼/cm2 단위로 표시되는 광량 측정기로서, 각각 light guide의 끝부분에 SUV 탐침기를 결합하여 측정하며, 자외선 조사 전과 조사 후에 측정값이 유지되는 지를 확인한다.Light intensity meter in units of ㎼ / cm 2 , measured by combining the SUV probe at the end of each light guide, and confirm that the measured value is maintained before and after UV irradiation.
(다) 표준시료(C) standard sample
「기능성화장품 심사에 관한 규정」(식품의약품안전처고시 제2015-14호)의 '자외선차단효과 측정방법 및 기준' 에 근거하여 높은 자외선차단지수의 표준시료를 제조하여 사용한다.Standard samples with a high UV protection index should be prepared and used in accordance with the "Methods and Standards for Measuring UV Protection Effects" of the Regulations on the Evaluation of Functional Cosmetics (KFDA No. 2015-14).
(4) SPF 측정결과(4) SPF measurement result
화장품 임상시험기관인 대한피부과학연구소에 본 연구과제로 수행된 선크림을 2명의 예비 피험자를 포함하여 총 12명의 본 피험자를 대상으로 제품의 자외선차단지수 평가 시험을 실시한 결과 평균 50.5±2.3의 자외선차단지수를 확인할 수 있었다. 시험의 신뢰성을 확보하기 위해 식품의약품안전처가 제시한 시험방법에 따라 표준시료를 제작하여 동시에 시험을 실시하였으며 평균 15.3±1.3의 자외선차단지수를 확인하였고 이는 [식품의약품안전처 고시 제2015-14호]에서 제시한 범위 15.5±3.0 내에 있었다. 본 시험을 통해 측정된 표준시료와 시험시료 각각의 자외선차단지수의 95% 신뢰구간은 측정치의 ±20% 이내로 확인되어 측정치의 신뢰성이 검증되었다. 결론적으로 제품은 SPF 50.5±2.3에 해당하는 자외선 단력을 가지고 있는 것으로 판단된다.Sunscreen index evaluation test of 12 subjects, including 2 preliminary subjects, was conducted at the Korean Dermatological Research Institute, a cosmetic clinical research institute, and the sunscreen index averaged 50.5 ± 2.3. Could be confirmed. In order to ensure the reliability of the test, standard samples were prepared and tested at the same time according to the test method suggested by the Ministry of Food and Drug Safety, and the UV protection index of 15.3 ± 1.3 was confirmed. ] Was within the range of 15.5 ± 3.0. The 95% confidence intervals of the UV protection index of each of the standard sample and the test sample measured through this test were confirmed to be within ± 20% of the measured value, thereby verifying the reliability of the measured value. In conclusion, the product is considered to have ultraviolet power equivalent to SPF 50.5 ± 2.3.
(5) PA 측정결과 (5) PA measurement result
화장품 임상시험기관인 대한피부과학연구소에 본 연구과제로 수행된 선크림을 2명의 예비 피험자를 포함하여 총 12명의 피험자를 대상으로 제품의 자외선A차단지수 평가 시험을 실시한 결과 평균 8.77±0.71의 자외선A차단지수를 확인할 수 있었다. 시험의 신뢰성을 확보하기 위해 식품의약품안전처가 제시한 시험방법에 따라 표준시료를 제작하여 동시에 시험을 실시하였으며 평균 4.04±0.41의 자외선A차단지수를 확인하였고 이는 [식품의약품안전처 고시 제2015-14호]에서 제시한 범위 3.75±1.01 내에 있었다. 본 시험을 통해 측정된 표준시료와 시험시료 각각의 자외선A차단지수의 포준 오차는 측정치의 ±10% 이내로 확인되어 측정치의 신뢰성이 검증되었다. 결론적으로 제품은 PFA 8.77±0.71, PA+++에 해당하는 자외선A차단력을 가지고 있는 것으로 판단된다.In the dermatology research institute, a cosmetics clinical research institute, a sunscreen conducted by this study was tested on a total of 12 subjects including two preliminary subjects. I could check the index. In order to ensure the reliability of the test, the standard samples were prepared and tested at the same time according to the test method suggested by the Ministry of Food and Drug Safety, and the UVA blocking index of 4.04 ± 0.41 was confirmed. Was within the range of 3.75 ± 1.01. The standard error measured by this test and the standardization error of the UVA blocking index of each test sample were confirmed to be within ± 10% of the measured value, thereby verifying the reliability of the measured value. In conclusion, the product is considered to have UVA blocking ability equivalent to PFA 8.77 ± 0.71 and PA +++.
이와 같이, 본 발명의 대추씨 추출물을 유효성분으로 포함하는 조성물은 티로시나아제 저해효과를 가져 미백효과를 가질 뿐만 아니라 엘라스타제 및 콜라게나제 활성을 저해시킴으로써 주름개선효과를 가진다. 또한, DPPH 자유 라디칼, ABST 라디칼 양이온, 과산화수소 및 수퍼옥사이드 음이온 라디칼 소거활성이 우수하여 항산화 효과가 있으며, 자외선에 조사에 의해 세포가 사멸되지 않아 자외선차단제로서 유용하게 사용될 수 있다. 또한 본 발명의 대추씨 추출물은 항균 활성이 우수하고, 세포 독성 및 피부 부작용이 없어 화장료, 약학적 및 식품 조성물에 안전하게 사용할 수 있다. As such, the composition comprising the jujube seed extract of the present invention as an active ingredient has a tyrosinase inhibitory effect and not only have a whitening effect, but also have an anti-wrinkle effect by inhibiting elastase and collagenase activity. In addition, the DPPH free radical, ABST radical cation, hydrogen peroxide and superoxide anion radical scavenging activity is excellent and has an antioxidant effect, the cell is not killed by irradiation with ultraviolet light can be usefully used as a sunscreen agent. In addition, the jujube seed extract of the present invention is excellent in antibacterial activity, there is no cytotoxicity and skin side effects can be used safely in cosmetics, pharmaceutical and food compositions.

Claims (5)

  1. 대추씨(Jujube seed) 추출물을 유효성분으로 포함하는 피부미백, 주름개선, 항산화 및 자외선차단을 위한 화장료 조성물. Cosmetic composition for skin whitening, anti-wrinkle, antioxidant and sun protection comprising jujube seed extract as an active ingredient.
  2. 대추씨 추출물을 유효성분으로 포함하는 피부미백, 주름개선, 항산화 및 자외선차단을 위한 약학적 조성물. A pharmaceutical composition for skin whitening, anti-wrinkle, antioxidant and sunscreen comprising jujube seed extract as an active ingredient.
  3. 대추씨 추출물을 유효성분으로 포함하는 피부미백, 주름개선, 항산화 및 자외선차단을 위한 식품 조성물. Food composition for skin whitening, anti-wrinkle, antioxidant and sunscreen comprising jujube seed extract as an active ingredient.
  4. 제 1 항 내지 제 3 항 중 어느 한 항에 있어서,The method according to any one of claims 1 to 3,
    상기 대추씨 추출물이 대추씨를 분쇄한 후 20 내지 95% 에탄올 수용액을 이용하여 20 내지 30시간 동안 침적시킨 후 회수한 다음, 여과지로 여과하고 농축하여 수득된 것임을 특징으로 하는 조성물.The jujube seed extract is pulverized jujube seed after 20 to 30 hours by immersion using 20 to 95% ethanol aqueous solution and then recovered, and then filtered by filter paper and concentrated to obtain a composition.
  5. 제 1 항 내지 제 3 항 중 어느 한 항에 있어서,The method according to any one of claims 1 to 3,
    상기 대추씨 추출물이 조성물 총 중량을 기준으로 하여 0.005 내지 50 중량%의 양으로 포함된 것을 특징으로 하는 조성물.The jujube seed extract is characterized in that it comprises an amount of 0.005 to 50% by weight based on the total weight of the composition.
PCT/KR2016/015026 2016-11-25 2016-12-21 Composition for skin whitening, wrinkle alleviation, antioxidation, and ultraviolet light blocking, containing jujube seed extract as active ingredient WO2018097388A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR1020160158685A KR101904216B1 (en) 2016-11-25 2016-11-25 A composition for skin whitening and improving skin wrinkle comprising extracts of jujube seed
KR10-2016-0158685 2016-11-25
KR10-2016-0158684 2016-11-25
KR1020160158684A KR101904215B1 (en) 2016-11-25 2016-11-25 A composition for antioxidating and blocking ultraviolet comprising extracts of jujube seed

Publications (1)

Publication Number Publication Date
WO2018097388A1 true WO2018097388A1 (en) 2018-05-31

Family

ID=62195161

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/015026 WO2018097388A1 (en) 2016-11-25 2016-12-21 Composition for skin whitening, wrinkle alleviation, antioxidation, and ultraviolet light blocking, containing jujube seed extract as active ingredient

Country Status (1)

Country Link
WO (1) WO2018097388A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109270057A (en) * 2018-10-17 2019-01-25 无限极(中国)有限公司 A kind of kit and its preparation method and application detecting skin-lightening cosmetic effect
KR20210044952A (en) * 2019-10-15 2021-04-26 농업회사법인다비치농산주식회사 Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component
CN115364147A (en) * 2022-09-26 2022-11-22 中国科学院昆明植物研究所 Jujube extract with antioxidant activity and alpha-glucosidase inhibitory activity and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070079638A (en) * 2006-02-03 2007-08-08 계명대학교 산학협력단 Extracts from zizyphus jujuba var. inermis rehder for antioxidation and functional food containing the same
KR20100046968A (en) * 2008-10-28 2010-05-07 박준홍 Soap containing the extracts of zizyphus jujube seed and manufacturing method of it
JP2010106001A (en) * 2008-10-31 2010-05-13 Theravalues Corp Ppar activator
KR20110103725A (en) * 2010-03-15 2011-09-21 서원대학교산학협력단 Cosmetic composition containing the extract of jujube extracted with high pressure
KR20110103604A (en) * 2010-03-15 2011-09-21 주식회사 엘씨에스바이오텍 Composition for protecting and improving skin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070079638A (en) * 2006-02-03 2007-08-08 계명대학교 산학협력단 Extracts from zizyphus jujuba var. inermis rehder for antioxidation and functional food containing the same
KR20100046968A (en) * 2008-10-28 2010-05-07 박준홍 Soap containing the extracts of zizyphus jujube seed and manufacturing method of it
JP2010106001A (en) * 2008-10-31 2010-05-13 Theravalues Corp Ppar activator
KR20110103725A (en) * 2010-03-15 2011-09-21 서원대학교산학협력단 Cosmetic composition containing the extract of jujube extracted with high pressure
KR20110103604A (en) * 2010-03-15 2011-09-21 주식회사 엘씨에스바이오텍 Composition for protecting and improving skin

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109270057A (en) * 2018-10-17 2019-01-25 无限极(中国)有限公司 A kind of kit and its preparation method and application detecting skin-lightening cosmetic effect
CN109270057B (en) * 2018-10-17 2021-07-20 无限极(中国)有限公司 Kit for detecting efficacy of whitening cosmetics and preparation method and application thereof
KR20210044952A (en) * 2019-10-15 2021-04-26 농업회사법인다비치농산주식회사 Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component
KR102355138B1 (en) * 2019-10-15 2022-01-26 농업회사법인다비치농산주식회사 Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component
CN115364147A (en) * 2022-09-26 2022-11-22 中国科学院昆明植物研究所 Jujube extract with antioxidant activity and alpha-glucosidase inhibitory activity and application thereof
CN115364147B (en) * 2022-09-26 2023-08-08 中国科学院昆明植物研究所 Fructus Jujubae extract with antioxidant activity and alpha-glucosidase inhibiting activity and its application

Similar Documents

Publication Publication Date Title
Tanveer et al. Molecular basis of skin photoaging and therapeutic interventions by plant-derived natural product ingredients: A comprehensive review
WO2020171364A1 (en) Cosmetic composition comprising azadirachta indica leaf extract
WO2017146414A1 (en) Composition for skin moisturization and skin wrinkle alleviation, containing α-terpineol as active ingredient
WO2018097388A1 (en) Composition for skin whitening, wrinkle alleviation, antioxidation, and ultraviolet light blocking, containing jujube seed extract as active ingredient
KR101908077B1 (en) Cosmetic composition for whitening, antiaging or skin wrinkle containing natural oriental medicine extracts
Chen et al. Photoprotection of maqui berry against ultraviolet B-induced photodamage in vitro and in vivo
WO2013129723A1 (en) Composition for improving skin conditions comprising hordenine
KR20090025497A (en) The cosmetics composition being contained pau d&#39;arco, tabebuia avellanedae extracts and having the effects of antiphlogistic and abirritation of skin
KR101904215B1 (en) A composition for antioxidating and blocking ultraviolet comprising extracts of jujube seed
KR20130072706A (en) Method for preparing paeonia lactiflora extracts containing taxifolin-3-glucoside and cosmetic composition containing preparing paeonia lactiflora extracts
WO2022085858A1 (en) Composition for whitening skin or ameliorating wrinkles comprising dendropanax morbiferus extract
KR20220133476A (en) Composition comprising Prunus persica extract
WO2014119826A1 (en) Cosmetic composition for whitening or wrinkle improvement which includes seaweed extract as active ingredient
KR101458013B1 (en) Composition for anti-oxidation and whitening and anti-wrinkle cosmetics comprising extract of un-ripening Pinus koraiensis Siebold et Zucc cone
WO2014003224A1 (en) Compositions for whitening skin comprising madecassoside
KR20140081137A (en) A skin-care agent containig Morchella esculenta fruit body extract or Morchella esculenta mycelium extract
KR20080004742A (en) Composition for skin whitening containing diosgenin
WO2018151563A1 (en) Composition for preventing photoaging and alleviating skin wrinkles, containing cosmos bipinnatus extract
KR101904216B1 (en) A composition for skin whitening and improving skin wrinkle comprising extracts of jujube seed
KR101317433B1 (en) The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage
WO2018105803A1 (en) Composition for skin whitening, antioxidation, wrinkle improvement, antimicrobial activity and anti-inflammation comprising unripe apple extract and baicalin as active ingredients
WO2013070018A1 (en) Composition comprising carnosic acid or derivative thereof
Li et al. Bioactivity and application of anthocyanins in skin protection and cosmetics: an extension as a functional pigment
KR20200046674A (en) A composition for antioxidating, whitening and improving wrinkle comprising extracts of black persimmon
KR101434163B1 (en) A pharmaceutical with anti oxidant, anti inflammatory and skin whitening effect comprising the extract from aerial part of pueraria thunbergiana

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16922097

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16922097

Country of ref document: EP

Kind code of ref document: A1